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ABSTRACT 
 Barriers against the external environment are crucial for sustaining life in 
multicellular organisms.  In mammals, epithelial barriers form following convergent 
growth and development of cell-cell junctions.  The characteristics of these junctions 
greatly influence the attributes of the tissues they compose, and vary considerably 
based on the location and function of the tissue.  At least four types of epithelial cell-cell 
junctions exist, the most apical of which is known as the tight junction (TJ).  Barrier 
forming tissues are often semi-permeable in nature owing to TJ architecture and the 
organization of the over 40 involved proteins.  These can be transmembrane or 
cytosolic, and are involved in cell signaling in addition to their barrier functions.  A 
specific transmembrane protein known as occludin is highly phosphorylated on its C-
terminal coiled-coil, and certain sites have been found to regulate specific aspects of TJ 
function, including the response to certain cytokines.   
 Previously, our lab discovered a novel phosphosite at serine 471 that is located 
at a contact site with an important scaffolding protein and central organizer of the TJ, 
zonula occludens-1.  Phosphoinhibitory, serine to alanine (S471A) occludin point mutant 
MDCK cell lines demonstrate that S471A monolayers are poorly organized with 
mislocalized TJ proteins, increased small solute flux, and decreased electrical 
resistance compared to WT occludin (WT Occ) or phosphomimetic, serine to aspartic 
acid (S471D) lines.  Additionally, S471A monolayers are composed of fewer, larger cells 
than controls, and exhibit proliferative arrest almost immediately following confluency, in 
contrast to control lines, which go through at least one additional round of proliferation.   
This phenotype including larger, less numerous cells and a low resistance barrier can 
xv 
 
be recapitulated with a cell cycle inhibitor, demonstrating that confluent proliferation or 
cell packing is necessary for barrier maturation.  G-protein coupled receptor kinase 
(GRK) was confirmed to be an S471 kinase by inhibitor experiments from a 
bioinformatically compiled candidate kinase list, and GRK inhibitors were able to 
recapitulate the disrupted monolayer and low resistance barrier of S471A lines. 
 Finally, S471A expression perturbed purified coiled-coil stability as determined by 
NMR.  Modeling of inter-coil interactions identified several possible hydrogen bonds in 
addition to the negative charge of the phosphate that differ between the phosphorylated 
and non-phosphorylated forms.  Expression of S471N (asparagine) transgenic occludin 
in vitro demonstrated highly organized border organization similar to WT Occ and in 
stark contrast to S471A, despite the lack of a negative charge at the S471 position.  
This result suggests that the border organization of p-S471 is not due to the negative 
charge at S471, and may be the result of differential intra-coil hydrogen bonding.   
In conclusion, cell packing is necessary for barrier maturation, and is regulated by the 
novel phosphosite, occludin S471.  S471 is an important contributor to confluent 
proliferation, monolayer maturation, and barrier resistance, and plays a role in the 
barrier regulatory function of occludin. 
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CHAPTER I 
Introduction 
 
 Multicellular organisms are by definition composed of multiple cells working 
together to accomplish processes necessary for survival of the organism.  Multicellular 
organismal composition can be advantageous in that it allows for division of labor 
among cells or groups of cells, which in turn can lead to morphological specialization 
that assists in completion of a specific task.  Groups of morphologically and 
occupationally similar cells can be composed into tissues, which can accomplish a 
dizzying array of functions throughout the organism.  In the case of epithelial cells, 
examples include regulating solute and water balance in the tubules of the kidney, 
facilitating absorption of water, nutrients, and electrolytes in the intestine, or activating 
site specific dermal proliferation in response to injury to close a wound in the skin. 
 For individual cells to able to coordinate their actions as part of a tissue, it is 
imperative that cell-cell signaling mechanisms for communication be present, and in the 
case of barrier forming tissues, a physical connection between adjacent cells must exist.  
Barrier forming tissues bestow obvious advantages on an organism by excluding 
potentially pathogenic material from the internal environment.  In many cases however, 
it is crucial that these barriers be semi-permeable, allowing passage of certain 
substances while blocking others.  This is true in the kidney tubule, in which various 
segments are more permeable either to solutes or to water, allowing the establishment 
and maintenance of an interstitial concentration gradient by which urine can be 
concentrated, allowing for reabsorption of valuable solutes and regulating water loss 
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(Vize et al., 2003).  Others occur in immune-privileged environments such as the 
mammalian testis, where adjacent sertoli cells form a barrier that excludes immune and 
macromolecules while allowing small molecule diffusion, or in the eye, in which the cells 
of the retinal-pigmented epithelium allow passage of oxygen and nutrients from 
choroidal blood vessels to the metabolically active outer retina while preventing 
passage of potentially deleterious solutes (Frey and Antonetti, 2011; Mruk and Cheng, 
2015).  While multiple types of cell-cell junctions exist and are important for cell and 
tissue functionality, the current project focuses primarily on tight junctions (TJs), which 
are classically known to regulate paracellular flux, and are increasingly implicated in 
additional roles such as cell signaling.  The current dissertation introduces the structure 
and relevant background of the four main cell-cell junctions, followed by two chapters of 
experimental data, and ending with discussion of the implications of the work and 
identification of limitations and future directions. 
. 
1.1 Aim and Scope 
 TJs are composed of many different proteins, some of which are cytosolic while 
others are transmembrane.  A specific transmembrane protein known as occludin plays 
an integral role in TJ regulation, and modification of its activity is associated with 
disease (further discussed in chapter II).  The current project is based on previous work 
demonstrating the existence of specific phosphorylation sites that contribute to occludin-
mediated regulation of the TJ (Murakami et al., 2009; Raleigh et al., 2011; Sundstrom et 
al., 2009), (further discussed in chapter III).  Proteomic experiments performed in the 
Antonetti Laboratory identified a number of novel phosphorylation sites (Sundstrom et 
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al., 2009).  The current study aims to investigate the role of a specific site, serine 471 
(S471).  S471 is a unique and particularly interesting site in that it sits at the center of an 
interaction domain between occludin and a known organizer and regulator of the TJ, the 
scaffolding protein zonula occudens-1 (ZO-1).  As a result, we postulated that S471 
may contribute to TJ integrity (such as permeability to ions, small molecules, or larger 
molecules), and might influence TJ morphology.  Furthermore, I examined kinases that 
might phosphorylate S471 and probed what interactions at the molecular level might 
provide mechanistic understanding of any effects.  Given the nature of the questions 
under investigation, a simple, in vitro system was needed and was used in the 
described experiments, supplemented by structural work using peptides and protein 
fragments. 
 
1.2 Study Overview 
 The current dissertation opens with a review of relevant literature broken into two 
parts: the first includes topics such as the overview, structure and function of the main 
cell-cell junction types and important proteins present at these junctions.  The second 
introduces the concepts of confluent proliferation, cell transitions, the role of biophysical 
forces, and other factors important in epithelial monolayer formation and maturation.  
This material is presented in chapter 2: Literature Review. 
 Original data presentation centers on characterizing the effects of occludin S471 
phosphorylation and determining the mechanisms at the cellular and molecular levels 
by which these effects occur.  Characterization of S471 phosphorylation was 
accomplished by expressing phosphoinhibitory (S471A) or phosphomimetic (S471D) 
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occludin in an immortalized epithelial cell line and observing the effects on TJ protein 
organization and barrier function.  This approach is informative in that serine and 
alanine are structurally identical except that serine has an ethanol side chain that can 
be phosphorylated, while alanine’s side chain terminates in a methyl group that cannot.  
Aspartic acid (D) has a carboxylic acid side chain that carries a permanent negative 
charge similar to a phosphate group, and mimics constitutive phosphorylation.  In the 
course of these experiments, it was unexpectedly discovered that inhibition of S471 
phosphorylation has dramatic effects on high confluency cell proliferation and 
monolayer maturation, leading to numerous studies measuring cell proliferation rate in 
the various mutants to further explore this effect.  These experiments led to 
identification of the necessity of cell packing for monolayer maturation and identification 
of a novel regulatory role for occludin in this process.  Since S471 is a recently identified 
site about which very little was known, substantial effort was devoted to identifying the 
kinase or kinases that phosphorylate this site.  This was done initially through a screen 
of bioinformatically identified putative kinases, and later confirmed with multiple 
inhibitors to kinases of interest.  These studies form the bulk of the dissertation, and are 
reported in chapter 3: Occludin S471 Phosphorylation Contributes to Tight Junction 
Formation and Cell Packing at Confluence. 
 As a result of the findings of chapter 3, structural experiments were performed in 
collaboration with colleagues at Pennsylvania State University School of Medicine, John 
Flanagan and Maria Bewley, to investigate specific interactions at the molecular level 
that might underlie the in vitro effects.  Nuclear magnetic resonance (NMR) experiments 
were carried out by our collaborators, which suggest that peptides expressing occludin 
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S471A or S471D mutations shift the structure of the occludin coiled-coil.  
Phosphorylation of serine changes the charge of the residue from neutral to negative, 
and adds a side chain phosphate group that is sterically larger, potentially leading to 
additional hydrogen bonding and other interactions with neighbors.  To examine the role 
of the negative charge apart from size and other factors, WT Occ, S471A, or S471N 
occludin was transiently transfected into MDCK cells followed by immunofluorescence 
(IF) to evaluate organization of TJ proteins at the border.  S471N mutant occludin 
retains the ability to hydrogen bond with nearby amino acids and is structurally very 
similar to S471D, but lacks the negative charge of the S471D or phosphorylated S471.  
These studies indicate that negative charge at S471 is not necessary for organized TJ 
protein localization at the border, suggesting that the effect of phosphorylation is 
through hydrogen bonding, or some other factor.  These results are reported in chapter 
4: Negative Charge at Occludin S471 is Not Necessary for Proper Localization and 
Organization of Tight Junction Proteins at the Border. 
 Following presentation of the results of chapter 4, the dissertation closes with a 
discussion of important findings and overall conclusions.  Methodological limitations are 
discussed, and areas for future investigations and broader application of the presented 
findings are identified.  These discussions make up chapter 5: Conclusions, Limitations, 
and Future Directions.   
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CHAPTER II 
Literature Review 
   
2.1 Epithelial Cell-Cell Interactions 
 Tissues in multicellular organisms are composed of many cells that act in a 
coordinated manner to adapt tissue characteristics in ways that are vital for survival.  
This requires individual cells to be connected to facilitate communication and 
coordinated action as a single tissue sheet or organ rather than a conglomeration of 
many individual cells.  These connections can be specialized for specific and diverse 
functions ranging from propagating electric signals in cardiomyocytes to regulating 
water and solute permeability in kidney tubule cells, or restricting movement of blood-
borne solutes across the outer blood retinal barrier into the predominantly 
immunoprivileged eye.  In epithelial cells, four basic cell-cell junctions exist. 
 
 2.1.1 Gap Junctions 
 Gap junctions (GJs) are basolaterally located and specialize in enabling cell-cell 
signaling (Fig. 2.1).  GJs are channels that span both membranes of adjacent cells and 
facilitate the flow of ions or other signaling molecules, allowing for rapid signal 
transduction between cells (Harris, 2001).  Classically, they are composed of members 
of a tetraspan transmembrane protein family known as connexins, which are arranged 
in a cylindrical pattern to form a hemichannel with an aqueous pore at the center (Herve 
and Derangeon, 2013).  Six connexins form a hemichannel on each side of the 
membrane that connects to a hemichannel on an adjacent cell to form a mature, 
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junction-spanning channel.  GJs are ubiquitously expressed, and play an especially 
pivotal role in cardiomyocytes, where they assist in action potentials transmission 
between cells, leading to coordinated contractile activity (Stroemlund et al., 2015).   
Alterations in connexin expression or organization are associated with cardiac 
arrhythmias and decreased contractile function (Severs et al., 2008).  Other electrically 
active cell types, including neural cells, can also be affected.  Mutation of the GJ 
protein, connexin 32, in Schwann cells of the peripheral nervous system leads to X-
linked Charcot-Marie-Tooth Disease and distal limb weakness (Nualart-Marti et al., 
2013).  Additionally, murine KO models of various connexins suffer from a range of 
symptoms ranging from arrhythmias (connexin 40) to cardiac related embryonic lethality 
(connexins 43 and 45), stressing the importance of GJs in highly conductive tissues 
(London, 2004).   
 
 
 2.1.2 Desmosomes 
 Just apical to GJs are desmosomes, cell-cell contacts involved in cell adhesion 
and traditionally described as “spot welds” (Getsios et al., 2004).  Desmosomes develop 
soon after cell-cell contact, and are composed of several proteins including 
transmembrane members of the cadherin superfamily, desmoglein and desmocollin, 
along with cytosolic desmoplakin, plakoglobin (also known as γ-catenin), and 
plakophillin (Nekrasova and Green, 2013).  Desmosome formation is associated with 
the adherens junction (AJ), specifically expression of E-cadherin (Lewis et al., 1997).  
Desmosomes are unable to form in E-cadherin KD cell lines, but are rescued by re-
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expression of E-cadherin along with plakoglobin.  Plakoglobin hepatic KO in mice 
compromises desmosome composition, rendering the animals more susceptible to 
tissue injury following insult compared to controls (Zhou et al., 2015).  Similarly, humans 
with the autoimmune disease pemphigus vulgaris express anti-desmoglein antibodies in 
keratinocytes, which disrupts desmosomes (Sajda et al., 2016).  This leads to 
decreased cell-cell adhesion and dermatological disruption, including chronic blistering.  
The association of desmosomal dysfunction with additional diseases including 
cardiomyopathy and cancer further indicates the importance of desmosomes in 
maintaining overall tissue integrity (Notari et al., 2015; Otsubo et al., 2015). 
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 2.1.3 Adherens Junctions 
 The apical junctional complex (AJC) is located apical to GJs and desmosomes, 
and is composed of AJs, and TJs (discussed in a later section) (Anderson et al., 2004; 
Farquhar and Palade, 1963; Tsukita et al., 1992).  As the name would suggest, AJs 
(also known as zonula adherens) contribute to cell-cell adhesion, but also establish a 
paracellular barrier to large solutes.  AJs are present in both vertebrates and 
invertebrates (Oda and Takeichi, 2011), and are thought to be the first junction to form 
Fig. 2.1: Epithelial cell-cell interactions.  (A) Schematic of the four main epithelial 
junctions: Gap junctions, desmosomes, adherens junctions, and tight junctions.  
Adherens junctions and tight junctions make up the apical junctional complex (AJC). 
(Image modified from Rossier et al., 2015). 
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following cell-cell contact (Sajda et al., 2016).  Recent studies have identified an 
increasingly broad AJ role that includes maintaining differentiation and discouraging 
tumorigenesis (Berx and van Roy, 2009; Stockinger et al., 2001).  
 AJs are composed of multiple proteins including a transmembrane protein known 
as E-cadherin, which has an intracellular, transmembrane, and extracellular domain 
(Shapiro and Weis, 2009).  E-cadherin serves as a major AJ cell adhesion molecule 
(CAM), and forms homophilic dimers in cis and trans in a Ca2+ dependent manner 
(Pertz et al., 1999). Cadherin-cadherin trans dimers are an important form of initial 
contact between converging cells that facilitates monolayer formation, and trans binding 
is sufficient to decrease proliferative rate, even in subconfluent cells (Kim et al., 2011; 
Perrais et al., 2007). The importance of E-cadherin in vivo is further illustrated by the 
embryonic lethality of E-cadherin KO mutant mice (Larue et al., 1994).  Finally, E-
cadherin expression is inversely correlated with many types of cancer (Giroldi et al., 
1994), and is a known tumor suppressor (Jeanes et al., 2008).  E-cadherin loss is 
associated with dedifferentiation and epithelial to mesenchymal transition (EMT), and is 
correlated with increased tumorigenesis and metastasis (Berx and van Roy, 2009, See 
section 2.2). 
 Intracellularly, E-cadherin interacts with β-catenin, which in turn binds to α-
catenin, which binds to F-actin, functionally connecting the AJ to the cytoskeleton 
(Gottardi and Gumbiner, 2001; Huber and Weis, 2001).  α-catenin deficient cells exhibit 
decreased aggregation (Watabe et al., 1994), and α-catenin KO has a similar effect in 
vivo (Vasioukhin et al., 2001). The role of α-catenin as a linker between β-catenin and 
the cytoskeleton has become controversial however, leaving the possibility that 
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additional proteins may be involved (Watabe-Uchida et al., 1998; Yamada et al., 2005).   
A potential contributor is p120-catenin (also known as CTNND1), which interacts with E-
cadherin and stabilizes it in the cell membrane. Expression of mutant p120 leads to 
increased E-cadherin internalization, but this effect is rescued by WT p120 (Liu et al., 
2007).  E-cadherin-catenin complex-based AJs contribute to AJ formation and 
development (Halbleib and Nelson, 2006), and together with the nectin-afadin complex 
plays a prominent role in cell adhesion (For discussion of nectin-afadin, see last 
paragraph of this section).   
 In addition to connecting E-cadherin to the cytoskeleton via α-catenin, β-catenin 
is necessary for the regulation of proliferation by cadherin-cadherin trans interactions 
(Perrais et al., 2007).  Free β-catenin can also translocate to the nucleus and serve as a 
transcriptional co-activator (MacDonald et al., 2009).  In this way, β-catenin serves as 
an important component of the Wnt signaling pathway (MacDonald et al., 2009).  In the 
absence of Wnt signaling, β-catenin is bound by a complex that includes glycogen 
synthase kinase (GSK), ubiquitinated, and marked for proteasomal degradation, while 
Wnt binding to its receptor inhibits GSK and allows β-catenin to translocate to the 
nucleus and transcribe genes involved in proliferation (Fig. 2.2, Baron and Kneissel, 
2013).  While progress has been made, additional work is needed to identify the 
subtleties of β-catenin’s diverse cellular functions (Gottardi and Gumbiner, 2001; 
Shapiro, 2001). 
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Fig. 2.2: Wnt signaling pathway.  The Wnt signaling pathway mediates proliferation 
through regulating the cellular localization of β-catenin.  When Wnt is inactive, β-
catenin is sequestered in the cytosol, bound by the β-catenin destruction complex, 
and degraded.  When Wnt is active, binding of Wnt to its receptor releases β-catenin 
from the complex and allows it to translocate to the nucleus, where it drives 
transcription of pro-proliferative genes as a transcriptional co-activator.  (Image from 
Staal and Clevers, 2005) 
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Nectin is a second transmembrane protein CAM that forms trans homodimers, 
and plays a role in cell adhesion similar to E-cadherin, but acts independent of Ca2+ 
(Fig. 2.3, Takahashi et al., 1999).  Nectin is connected to the cytoskeleton by binding to 
the PDZ domain of the linker protein, afadin, which connects to the cytoskeleton through 
its F-actin binding domain (Mandai et al., 1997).  The nectin-afadin complex seems to 
be associated with the E-cadherin-α, β-catenin complex, as nectin and afadin colocalize 
with E-cadherin in cells that do not express tight junctions (TJs), and nectin helps 
localize E-cadherin at the junction (Mandai et al., 1997; Tachibana et al., 2000).  
Furthermore, microbead-bound E-cadherin extracellular domain binds the catenins, but 
also localizes the nectin-afadin complex to cell-bead junctions (Honda et al., 2003).   
Inhibition of the nectin complex also inhibits E-cadherin AJs (Honda et al., 2003); 
however, studies presented in this dissertation demonstrate that E-cadherin and β-
catenin can be localized at the border even when afadin is mislocalized (see chapter 3).  
Murine afadin KO impairs both ectoderm organization and mesoderm migration (Ikeda 
et al., 1999).  Paracellular permeability is also increased, as is susceptibility to tissue 
injury induced by dextran sulfate sodium (Tanaka-Okamoto et al., 2011).  Furthermore, 
there is evidence that the nectin-afadin complex is involved in AJ and TJ formation.  TJ 
proteins such as claudin, occludin, and zonula occludens-1 (ZO-1) localize to the 
junction in nectin-expressing MDCK cells, and ZO-1 initially binds near the nectin-afadin 
complex, then migrates apically (Fukuhara et al., 2002a; Fukuhara et al., 2002b).  
Microbeads bound to the nectin extracellular domain also localize with ZO-1 (Fukuhara 
et al., 2002a).  More recent studies indicate that following its temporary interaction with 
afadin, ZO-1 moves on and interacts with the TJ protein, junctional adhesion molecule 
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(JAM, see next section) (Ooshio et al., 2010).  Afadin KD in MDCK cells prevents both 
AJ and TJ formation, while KD of the TJ protein ZO-1 only affects TJs (Ooshio et al., 
2010).  Finally, inhibition of nectin dimerization prevents localization of occludin or 
claudin at the junction (Fukuhara et al., 2002b), but nectin-afadin complexes and TJs 
are formed in the absence of the cadherin complex (Yamada et al., 2006).  While the 
exact protein-protein interactions and mechanistic sequence of events remains elusive, 
these findings strongly suggest that the nectin-afadin complex makes important 
contributions to AJ and TJ formation.  
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Fig. 2.3: Structure of the apical junctional complex (adherens and tight 
junctions).  Adherens junction (AJ) and tight junction (TJ) between two adjacent 
epithelial cells, depicting relevant proteins.  These include the transmembrane 
proteins occludin, claudin, JAM, nectin, and E-cadherin, and the cytoskeletal proteins 
ZO-1, 2, 3, afadin (AF6), and p120, α and β catenin.  (Image from Kooistra et al., 
2007). 
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 2.1.4 Tight Junctions 
Adherence of adjacent cells by establishment of AJs is followed by the formation 
of other specialized cell-cell contacts known as tight junctions (TJs).  TJs are a feature 
of many different types of epithelial and endothelial cells in many species of vertebrates, 
and are homologous to the septate junctions found in Drosophila melanogaster (Willott 
et al., 1993).  First described in 1963 (Farquhar and Palade, 1963), TJs traditionally 
have the roles of maintaining apical-basolateral polarity by restricting the movement of 
specific membrane proteins to the opposite side of the cell (the fence function, which 
has become controversial in recent years, (Umeda et al., 2006), and establishing 
selectively permeable paracellular barriers between adjacent cells (the gate function, 
D'Atri and Citi, 2002; Diamond, 1977).  In the latter case, this barrier is vital for selective 
absorption of electrolytes and solutes in tissues such as the kidney and intestine, and 
also allows for establishment of blood barriers in immunoprivileged tissues including the 
brain, eye, and testes.  Freeze fracture electron microscopy images show that TJs take 
the form of many strands laterally encircling the apical cell, interacting with each other 
and with TJ proteins on membrane leaflets of the adjacent cell (Fig. 2.4, Staehelin, 
1973; Staehelin, 1974). 
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Transmembrane TJ Proteins 
Over 40 TJ proteins have been identified to date including transmembrane 
proteins, which facilitate restriction of paracellular flux, and cytosolic proteins which 
serve as organizers of transmembrane proteins and connect them to the cytoskeleton 
(Schneeberger and Lynch, 2004).  The result is a continuous junction that stretches 
from the cytoskeleton across the membrane to TJ proteins on adjacent cells (Fanning et 
al., 1998).  The tetraspan transmembrane protein, occludin (also called MARVELD1, 
Furuse et al., 1993) is located in the membrane of mature epithelial monolayers, 
Fig. 2.4: Tight Junction Strands Visible Via Freeze-Fracture Microscopy.  
Electron microcopy image of epithelial cell apical aspect.  Adjacent cell membrane 
has been removed to expose the Intertwining TJ strands in the YZ plane (arrow, 
image modified from Furuse, 2010). 
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forming homodimers in cis through its coiled-coil domain (Nusrat et al., 2000; Raleigh et 
al., 2011), and interacting homophilically in trans (Bellmann et al., 2014).  Peptides 
encoding a central region of the second extracellular occludin loop (AA 210-228) bind 
occludin and other transmembrane TJ proteins, and interact with the TJ in vitro to the 
exclusion of endogenous TJ proteins (Nusrat et al., 2005).  Occludin is an important 
contributor to the TJ as overexpression increases trans-epithelial electrical resistance 
(TER) in MDCK cells (Balda et al., 1996; Van Itallie et al., 2010), and partial deletion of 
either extracellular loop attenuates the overexpression-mediated TER increase (Balda 
et al., 2000).  However, occludin KD/KO yields complex results.  As the first 
transmembrane TJ protein discovered, occludin was originally assumed to physically 
“occlude” paracellular flux and was named accordingly.  This notion was subsequently 
dismissed however when occludin KO mice were found to have TJs that were 
anatomically normal and did not exhibit increased permeability or decreased TER 
(Saitou et al., 2000; Schulzke et al., 2005).  Similarly, occludin KD via siRNA in MDCK 
cells did not affect TER in the steady state or following a Ca2+ switch assay (Yu et al., 
2005).  Closer analysis revealed however that occludin KO animals exhibit a 
constellation of phenotypes consistent with barrier dysregulation including brain 
calcification, male sterility, maternal inability to nurse, and gastric epithelial hyperplasia 
(Saitou et al., 2000; Schulzke et al., 2005).  These mice also undergo hair cell apoptosis 
in the inner ear, resulting in deafness several weeks after birth (Kitajiri et al., 2014).  A 
possible explanation for the absence of increased TJ permeability in these animals is 
compensation by a related protein with structural similarities, known as tricellulin or 
MARVELD2 (discussed later in this chapter), which is normally present at tricellular tight 
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junctions (tTJs) but is found at bicellular tight junctions (bTJs) in these animals and after 
occludin KD in vitro (Ikenouchi et al., 2008; Kitajiri et al., 2014).  These findings have 
contributed to the prevailing view that occludin acts as an important regulator of the TJ.  
Occludin is a multi-phosphorylated protein, particularly on its C-terminal coiled coil 
region (Sundstrom et al., 2009).  Early studies found that truncation of the coiled-coil 
region leads to increased permeability and decreased TJ organization, and changes in 
TER are correlated with changes in phosphorylation (Balda et al., 1996; Clarke et al., 
2000).  Increasingly, accumulating evidence suggests that specific amino acids mediate 
the TJ response to specific factors or cytokines and represent a mechanism of occludin-
mediated TJ regulation (see chapter 3 for further discussion). 
Additional studies have identified an inverse relationship between permeability 
and occludin content across many tissues (Antonetti et al., 1998; Hirase et al., 1997; 
Wong and Gumbiner, 1997), and identified a role for occludin in diverse diseases.  
Occludin is downregulated in many inflammatory diseases, including Crohn’s and 
ulcerative colitis (Bertiaux-Vandaele et al., 2011; Coeffier et al., 2010; Vivinus-Nebot et 
al., 2014).  TJs present a physical obstacle for pathogen entry into cells, and occludin is 
frequently targeted by viruses including: Norovirus (Troeger et al., 2009), HIV (Nazli et 
al., 2010), and Dengue virus (Talavera et al., 2004), and bacterial (including 
Campylobacter jejuni (Elmi et al., 2015), Porphyromonas gingivalis  (Nakajima et al., 
2015), and Pseudomonas aeruginosa elastase (Nomura et al., 2014) pathogens.  
Hepatitis C viral infection is normally restricted to cells of primate origin, but infection of 
murine cells is possible by overexpressing occludin.  Additionally, KD of occludin in 
normally permissive human cells attenuates infection, suggesting that occludin is 
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necessary for hepatitis C infection.  (Ploss et al., 2009).  Furthermore, certain viruses, 
including Coxsackie B and Adenoviruses, bind to a specific transmembrane protein 
known as the Coxsackie Adenoviral Receptor (CAR) to facilitate cellular entry (Coyne 
and Bergelson, 2006).  Occludin is endocytosed along with Coxsackie B virus and is 
necessary for infection, demonstrating utilization of the TJ and occludin by pathogenic 
microorganisms (Coyne et al., 2007).   
A new role for TJ proteins as regulators of proliferation and the cell cycle has 
recently been discovered, specifically for occludin loss as an emerging factor in the 
development of several types of cancer (Tobioka et al., 2004; Nemeth et al., 2009). 
Downregulation or loss of TJ proteins including occludin is associated with decreased 
epithelial character and epithelial to mesenchymal transition (EMT), associated with 
increased cancer risk (see chapter 3 for discussion.)  These findings confirm the 
physiological importance of occludin for exclusion of inflammatory factors and 
pathological agents as well as for proliferative control, and demonstrate increased 
disease susceptibility when altered.  
Occludin is a member of the myelin and lymphocyte (MAL) and related proteins 
for vesicle trafficking and membrane link (MARVEL) protein family, which specialize in 
membrane coherence and are especially prevalent in cholesterol rich regions (Sanchez-
Pulido et al., 2002).  In addition, occludin is one of three known members of the tight 
junction-associated MARVEL protein (TAMP) subfamily, which form selective barriers 
based on size (Raleigh et al., 2010).  All three TAMPs have a similar tetraspan 
transmembrane structure and cellular roles that are at least partially unique (Raleigh et 
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al., 2010).  The remaining two members of the TAMP family are tricellulin (also known 
as marvelD2), and the recently discovered marvelD3 (Steed et al., 2009). 
As suggested by its name, tricellulin is typically found at tTJs, and is recruited 
there by the novel tTJ protein, LSR (Masuda et al., 2011).  The convergence of three 
cells requires a specific junctional connection. The cells are assembled with a central 
tube at its center, a space approximately 10 nm in diameter and 1 µm in length 
(Staehelin, 1973).  Flux at this tube is regulated by tricellulin, and while the tTJ is a 
minor route for small ion flux, it is thought to play a significant role in the flux of 
macromolecules (Krug et al., 2009).  Despite its tricellular localization, both tTJ and bTJ 
are poorly organized after tricellulin KD, indicating a tricellulin effect on bTJs as well 
(Ikenouchi et al., 2005).  Tricellulin is found at bTJs in cases of occludin loss or tricellulin 
overexpression in animal and cell models, and may compensate for occludin (Ikenouchi 
et al., 2008; Krug et al., 2009).  Tricellulin mutant or KO mice are viable, but exhibit 
deafness due to loss of K+ gradient in endolymph and subsequent apoptosis of hair 
cells in the organ of Corti of the inner ear (Kamitani et al., 2015; Nayak et al., 2013).  
Additionally, post-natal deafness observed in occludin KO animals is proposed to be 
due to tricellulin compensation via tricellulin reallocation from tTJs to bTJs, and the 
resulting lack of tricellulin at tTJs (Kitajiri et al., 2014). 
MarvelD3 is a recently identified TAMP which localizes to bTJs, and colocalizes 
with occludin and the scaffolding protein ZO-1 (Raleigh et al., 2010).  MarvelD3 does 
not interact homophilically in trans (on adjacent cells, and opposite sides of the 
paracellular space), but interacts with itself, occludin, and tricellulin in cis (on the same 
side of the paracellular space, Cording et al., 2013).  TJ assembly as assessed by 
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maximum TER is delayed but not inhibited by marvelD3 silencing, and marvelD3 
expression is unable to rescue this delay in the absence of tricellulin or occludin, 
suggesting at least partially non-redundant function (Raleigh et al., 2010).  Instead, 
marvelD3 is involved in proliferative control, as KD increases proliferation in Caco-2 
intestinal cells while re-expression in tumor cells decreases proliferation (Steed et al., 
2014).  MarvelD3 expression decreases phosphorylation of the MAPK family member, 
JNK, which is involved in the response to environmental stresses, and activates nuclear 
transcription factors controlling proliferation and apoptosis (Davis, 2000; Steed et al., 
2014).  This results in decreased JNK activity leading to decreased proliferation.  
Additionally, marvelD3 is downregulated during EMT in cancer cells (Kojima et al., 
2011).  This suggests that marvelD3 contributes to proliferative regulation, possibly by 
acting as a connector between JNK and the TJ. 
In addition to the TAMPs, a second tetraspan transmembrane protein family, 
known as the claudins, is also found at TJs.  Claudins regulate paracellular flux and are 
found at regions where adjacent cell membranes are so close that the paracellular 
space is undetectable by electron microscopy, known as kissing points (Tsukita et al., 
2001).  Claudin subtypes form homo and heterodimers in cis and interact with each 
other homophilically in trans (Cording et al., 2013; Piontek et al., 2011).  There are 
currently 27 known members of the claudin family in mammals (Soini, 2011), some of 
which seal the barrier (1,3,5) while others, known as conductive claudins, form selective 
pores (Krug et al., 2014).  Selectivity can be for anions (17), cations (15), or for water 
(2) (Gunzel and Fromm, 2012; Krug et al., 2014).  Furthermore, the claudins can be 
classified as either classic (ex. 1-10) or non-classic (ex. 11-13) based on sequence 
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homology (Krause et al., 2008).  In vitro/in vivo KD/KO of various members of the 
claudin family results in increased permeability (claudins 4 and 18, (Kage et al., 2014; Li 
et al., 2014), aberrant permeability regulation (claudins 2 and 10 (Breiderhoff et al., 
2012; Muto et al., 2010) or lethality (claudin 1, (Furuse et al., 2002).  Additionally, 
claudin perturbation is associated with many clinical pathologies including inflammatory 
bowel disease (Weber et al., 2008), Crohn’s disease (Zeissig et al., 2007), ulcerative 
colitis (Oshima et al., 2008), breast and colon cancer (Kinugasa et al., 2010; Kulka et 
al., 2009), and the dermatological disease, ichthyosis (Hadj-Rabia et al., 2004), Taken 
together, these findings strongly suggest an important role for claudins in TJ 
functionality. 
Finally, members of the third TJ transmembrane protein family are known as 
junction adhesion molecules (JAMs).  The JAM family consists mainly of three 
members, JAMs A-C, which differ in amino acid sequence but share an intracellular 
sequence approximately 50 amino acids in length (Ebnet et al., 2004).  A larger 
subfamily of proteins, including JAM4, are related but exhibit prominent differences, 
including length of intracellular tail.  Epithelial cells express JAM-A, which forms 
homodimers in cis and interact with adjacent homodimers in trans (Kostrewa et al., 
2001; Prota et al., 2003).  Prevention of homodimerization disrupts localization and 
decreases TER following Ca2+ switch, suggesting a role for JAM-A in barrier assembly 
(Mandell et al., 2004).  JAM-A KD decreases TER and increases solute flux, indicating a 
leaky barrier (Laukoetter et al., 2007).  Additionally, genetic deletion of JAM-A increases 
intestinal permeability, and renders mice more susceptible to dextran sulfate sodium-
induced tissue damage (Laukoetter et al., 2007).  This is in agreement with studies 
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reporting that JAM-A is reduced in human inflammatory bowel disease (Vetrano et al., 
2008), and is decreasingly localized at TJs by the inflammatory cytokine, interferon 
gamma (Bruewer et al., 2005).  JAMs also interact with Par3 of the Par3/Par6/aPKC 
polarity complex and assist in localizing the complex to the TJ (Ebnet et al., 2001).  
While JAMs can be found very near TJ strands in MDCK cells, JAM expression in TJ 
null cells is not sufficient to form TJ strands (Itoh et al., 2001).  This is in contrast to 
claudins and suggests that JAMs do not share the paracellular flux restricting role of 
claudins (Furuse et al., 1998).  Occludin, the claudins, and the JAMs therefore have 
differing roles in the restriction, facilitation, and regulation of paracellular flux.  
Scaffolding TJ Proteins 
The cytosolic domains of occludin, the claudins, and the JAMs interact with a 
family of scaffolding proteins located in the cytosolic plaque near the cell membrane, 
known as the zonula occludens (ZO-1, 2, and 3) (Itoh et al., 1999; Li et al., 2005; Lye et 
al., 2010).  Originally identified in 1986, ZO-1 is a central organizer of the TJ that has 
many binding partners including transmembrane, cytosolic, and cytoskeletal proteins, 
making it a linker between the cytoskeleton and the barrier (Fanning et al., 1998; 
Stevenson et al., 1986).  All three ZO proteins contain 3 PSD/DlgA/ZO-1 (PDZ) regions 
with which they interact with transmembrane proteins like claudins and JAMs, and with 
each other (Lye et al., 2010).  They are also members of the membrane associated 
guanylate kinase (MAGUK) protein family, and have the characteristic guanylate kinase-
like (GuK) domain, which serves as a specialized Ser/Thr binding pocket and facilitates 
interaction with occludin (Tash et al., 2012; Zhu et al., 2011).  In addition, ZO-1/2 have 
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an N-terminal actin binding region (ABR) with which they interact with the cytoskeleton 
(Fig. 2.5). 
 
 
Fig. 2.5: Structure and domains of zonula occludens (ZO) proteins.  ZO-1, 2, 
and 3 are scaffolding proteins that interact with many binding partners via their 
multiple binding domains.  All three have three PDZ domains and one SH3, U5, 
GUK, and U6 domain.  ZO-1/2 also have an N-terminal actin binding region (ABR) 
while ZO-3 does not.  Proteins that interact with ZO at specific sites are noted above 
each domain.  (Image from Lye et al., 2010). 
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Truncation and deletion experiments have determined that the first two PDZ 
domains, the SH3, and both the U5 and U6 domains are all necessary for ZO-1, 
claudin-2, and occludin localization at junctions (Rodgers et al., 2013).  The interaction 
between ZO-1 and F-actin is not necessary for junctional localization of these proteins, 
but deletion of the ZO-1 ABR changes cell border morphology from wavy and tortuous 
to very straight, suggesting changes to cytoskeletal organization.  While a TJ protein, 
ZO-1 also associates with proteins of other cell-cell contacts including AJs (α-catenin) 
and GJs (connexin) (Itoh et al., 1997; Kausalya et al., 2001).  ZO-1/2 have at least 
partially overlapping roles leading to compensation in single KD experiments (Umeda et 
al., 2006).  As a result, ZO-1/2 double KD cells are badly disorganized, fail to assemble 
the TJ, and exhibit reduced TER, but ZO-1 or ZO-2 single KD cells do not (Rodgers et 
al., 2013; Umeda et al., 2006).  This compensation appears to be insufficient in vivo 
however, as both ZO-1 and ZO-2 single KO mutations are embryonic lethal (Katsuno et 
al., 2008; Xu et al., 2008).  ZO-3 exogenously expressed in ZO-1/2 double KD, ZO-3 
null cells fails to locate at the border, and ZO-3 KO mice are viable, suggesting distinct 
roles for ZO-1/2 and ZO-3 (Umeda et al., 2006; Xu et al., 2008).  
Proliferation and AJC Proteins 
Recent studies have demonstrated novel roles for the AJC in cell signaling and 
growth control in addition to canonical regulation of paracellular permeability/cell 
adhesion.  In contrast to the seemingly static nature of AJC proteins in fixed images, 
high trafficking of some TJ proteins (Shen et al., 2008) and distinct protein localization, 
creates separate protein pools. Proteins such as p120 catenin, ZO-2 and β-catenin 
locate to the nucleus where they can influence transcriptional activity (Spadaro et al., 
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2012; Zhang et al., 2011).  In the case of β-catenin, the target is the Wnt pathway 
transcription factor, TCF/LEF, which transcribes pro-proliferative genes in response to 
β-catenin (MacDonald et al., 2009).  β-catenin KO is sufficient to reduce proliferation-
induced hepatic tumors (Singh et al., 2014), suggesting that the role of E-cadherin in 
proliferative control may simply be to sequester β-catenin at the membrane, preventing 
nuclear translocation (see section 2.2).  In addition to stabilizing E-cadherin at the 
membrane, p120-catenin can also localize to the nucleus and influence transcriptional 
activity.  Increased nuclear p120 catenin localization is implicated in breast cancer 
progression via antagonizing the transcriptional repressor, Kaiso (van de Ven et al., 
2015), and p120 phosphorylation at specific sites is associated with increased lung 
cancer invasiveness (Zhang et al., 2011).  Conditional KO mouse studies have 
demonstrated that p120-catenin also has tumor suppressive activity (Schackmann et 
al., 2013). 
Occludin is present at multiple cellular locations, and plays a particularly 
important role in growth control.  Occludin is located at centrosomes in cells and 
increases Ser490 phosphorylation upon proliferation (Runkle et al., 2009).  
Phosphorylation of occludin S471 is associated with confluent proliferation, and 
phosphorylation inhibition at this site results in proliferative arrest (see chapter 3).  Loss 
of occludin is also associated with increased proliferation in cells and intestinal 
hyperplasia in occludin KO animals (Saitou et al., 2000; Wang et al., 2005).  Crucially, 
occludin re-expression in Raf-1 transformed cells is sufficient to reverse the proliferative 
phenotype of these cells both in vitro, and upon implantation in mice (Wang et al., 
2005).  These findings indicate a role for occludin in proliferative regulation. 
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Addionally, involvement in proliferation has been observed in several other AJC 
proteins.  JAM-A KO/KD increases cell proliferation, but this effect can be rescued 
through re-expression (Nava et al., 2011).  This is suggested to be due to JAM-A 
antagonism of Akt, and the prevention of β-catenin activation and nuclear translocation, 
demonstrating TJ regulation of specific proliferation-associated signaling pathways 
(Nava et al., 2011).  In addition, ZO-1/2 are both present at the nucleus in subconfluent 
cells and after wounding, but locate to the TJ upon confluence (Gottardi et al., 1996; 
Islas et al., 2002).  ZO-2 is clearly involved in proliferative control, though reports 
conflict as to whether it increases or decreases proliferation.  ZO-2 is reportedly 
associated with decreased cell proliferation (Gonzalez-Mariscal et al., 2009; Huerta et 
al., 2007) and increased apoptosis (Walsh et al., 2010), and with cancer when mRNA 
levels are decreased (Paschoud et al., 2007).  However, ZO-2 KO mice exhibit 
decreased proliferation and increased apoptosis (Xu et al., 2008).  This suggests that 
ZO-2 may act in a context specific manner.  Finally, the ZO proteins interact with ZO-1-
associated nucleic acid binding domain (ZONAB), a TJ-associated transcription factor 
that interacts with ZO-1 at its SH3 domain and regulates promotor activity (Balda and 
Matter, 2000).  Cell proliferation and density are increased by ZONAB overexpression 
and decreased by depletion (Balda et al., 2003).  Cytosolic  sequestration of ZONAB 
decreases cell proliferation and nuclear localization of both ZONAB and cell division 
kinase 4, suggesting that ZONAB may contribute to proliferative control at least in part 
through nuclear trafficking of other proteins (Balda et al., 2003).  These findings dispute 
the archaic model of the AJC as a static, monofunctional structure, and instead indicate 
that AJC proteins actively participate in cell signaling and growth control. 
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2.2 Cell Monolayer Formation 
2.2.1 Cellular Transitions 
Mammalian bodily tissues develop from one of the three germ layers that emerge 
following gastrulation: ectoderm (skin, hair), mesoderm (bones, blood vessels), and 
endoderm (liver, pancreas) (Gilbert, 2000; Solnica-Krezel and Sepich, 2012).  The 
phenotype of differentiated cells is influenced by lineage.  This is particularly evident in 
comparing mesoderm-derived mesenchymal cells, which are characterized by motility, 
invasiveness, and migratory ability, with epithelial cells which are stationary and express 
adhesion proteins that connect them to their neighbors (Kalluri and Weinberg, 2009; 
Thiery, 2002).  Phenotypic plasticity is such that in certain situations during 
development or in pathology, cells of epithelial or mesenchymal origin will take on 
characteristics of and transition into the other type of cell (Nakaya and Sheng, 2013; 
Sheng, 2015; Yao et al., 2011; Yilmaz-Ozcan et al., 2014).  This occurs in a process 
known as epithelial to mesenchymal transition (EMT), which is a natural part of 
embryogenesis and development, but is also implicated in cancer development and has 
been the focus of intensive studies (Kalluri, 2009; Kalluri and Weinberg, 2009). 
The inverse and less studied process is known as mesenchymal to epithelial 
transition (MET).  While MET has recently been implicated in re-differentiation of 
secondary tumors, it also plays a role in specific developmental events, most notably in 
the kidney (Rothenpieler and Dressler, 1993; Yao et al., 2011).  During early kidney 
development, a mass of epithelium known as the ureteric bud is exposed to growth 
factors by surrounding mesenchyme that induces branching of the epithelium, forming 
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primitive structures that will eventually become nephrons (Herzlinger et al., 1992; 
Saxén, 1987).  In most tissues, the surrounding mesenchyme contributes growth factors 
and influences development of the encircled epithelium, but does not itself become part 
of the mature organ.  However, through MET, some of these nephrotic mesenchymal 
cells differentiate into epithelium and are incorporated into the mature kidney.  The 
transition from densely packed mesenchyme to epithelium begins roughly 24 hours after 
induction, and is completed within the next 12 hours (Davies and Garrod, 1995).  During 
this period, previously mesenchymal cells stop expressing mesenchymal proteins such 
as fibronectin and instead express AJ and desmosomal proteins such as E-cadherin 
and the desmoplakins in conjunction with polarization (Garrod and Fleming, 1990; 
Thiery, 2002; Vestweber et al., 1985; Yilmaz-Ozcan et al., 2014).  Transitioning cells 
also lose mesenchymal characteristics such as high motility, linear proliferative rate, 
and inability to form cell-cell junctions, and take on epithelial characteristics including 
decreased motility, decreased proliferative rate, and mature cell-cell junctions that form 
a mature monolayer.  This process of MET may be modeled in cell culture as cells 
reach confluency and differentiate into a mature epithelium (Puliafito et al., 2012).  
2.2.2 Contact Inhibition 
Contact inhibition of proliferation (CIP) is a characteristic of epithelia in which 
previously proliferative cells come into physical contact with each other, and greatly 
decrease or cease proliferative growth despite the continued presence of nutrients 
(McClatchey and Yap, 2012; Puliafito et al., 2012).  Motility is also affected in highly 
confluent cells in a related process known as contact inhibition of locomotion (CIL, also 
called contact mediated inhibition of cell migration), defined as cessation of cell motility 
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in a specific direction following cell-cell contact (Abercrombie, 1979; Batson et al., 2013; 
Mayor and Carmona-Fontaine, 2010; Puliafito et al., 2012).  Both processes have the 
obvious advantages of facilitating mature monolayer formation while discouraging 
tumorigenesis.  CIL at low confluency often leads to motility in a different direction 
following a collision and thus cell scattering, but effectively prevents single cell motility in 
high confluency conditions Aston et al., 2010; Puliafito et al., 2012).  This is evident in 
developing epithelial monolayers and during wound healing, and loss of CIL is thought 
to be a contributor to metastatic potential (Astin et al., 2010; Middleton, 1972; Puliafito 
et al., 2012; Vermeulen et al., 1995).  In MDCK, subconfluent cells exhibit certain 
mesenchyme-like characteristics such as linear proliferative growth, cell motility about 
the substrate, development of cellular protrusions, and lack of clear TJ border staining 
(Mishima et al., 2002; Puliafito et al., 2012).  These characteristics are lost however in 
favor of differentiated epithelial characteristics following cell-cell contact, CIP, and CIL, 
leading to sweeping morphological changes, most prominently the loss of protrusions 
and acquisition of the familiar cobble-stone appearance.  While CIP and CIL are both 
important processes for the MET-like changes that occur during monolayer formation, 
the mechanisms behind CIL remain largely elusive (reviewed in Mayor and Carmona-
Fontaine, 2010).  Accordingly, the following sections will primarily just consider the 
contributions of CIP. 
  2.2.3 Hippo/MST Pathway 
An important contributor to CIP is the Hippo/MST Pathway, a cell membrane to 
nucleus signaling pathway originally discovered in Drosophila melanogaster that is 
involved in proliferation and cell survival, and alters transcription based on the 
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extracellular environment.  Epithelial cells express the AJ protein E-cadherin, which has 
an extracellular domain that interacts homophilically when adjacent cells that come 
within close physical proximity.  E-cadherin binding initiates a kinase cascade in the 
canonical hippo/MST pathway in which the central serine/threonine kinase, Mammalian 
Sterile 20-like 1 and 2 (MST1/2, known as Hippo in Drosophila), is bound to a 
scaffolding protein known as Salvador (SAV1), and phosphorylates the downstream 
kinases Large Tumor Suppressor 1 and 2 (LATS1/2, Warts in Drosophila) (Gumbiner 
and Kim, 2014; Johnson and Halder, 2014; Kim et al., 2011).  LATS1/2 interacts with a 
scaffolding protein and co-factor known as MOB1 and phosphorylates Yes-Associated 
Protein 1 (YAP) and Transcriptional-Co-Activator with PDZ Binding Motif (TAZ, also 
known as WWTR1).  YAP and TAZ are both transcriptional co-activators, and must 
associate with other transcription factors such as TEAD or SMAD to drive transcription.  
When the Hippo/MST Pathway is off, YAP and TAZ are dephosphorylated and free to 
locate to the nucleus where they interact with TEAD and SMAD and transcribe genes 
involved in cell proliferation and survival.  When the Hippo/MST Pathway is activated, 
YAP and TAZ are phosphorylated by LATS1/2, excluded from the nucleus, and marked 
for ubiquitination and eventual degradation, preventing proliferative transcription (Fig. 
2.6, Johnson and Halder, 2014). 
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 2.2.4 E-cadherin, β-catenin, and CIP 
E-cadherin plays an important role in CIP and proliferative control, primarily by 
binding β-catenin of the Wnt signaling pathway (discussed in an earlier section) and 
initiating Hippo/MST signaling.  Microbeads expressing E-cadherin extracellular domain 
are able to suppress MDCK proliferation in a manner dependent on β-catenin and 
Hippo/MST (Kim et al., 2011; Perrais et al., 2007).  Expression of extracellular domain-
deleted E-cadherin decreases proliferation, while intracellular domain-deleted E-
Fig. 2.6: Vertebrate Hippo/MST signaling.  Schematics of (A) inactive and (B) active 
Hippo/MST signaling.  When Hippo/MST is inactive, YAP/TAZ are not phosphorylated 
and free the transcriptional co-activators, YAP/TAZ, allowing their translocation to the 
nucleus where they are responsible for transcription of pro-proliferative genes.  When 
Hippo/MST is activated through homophilic E-cadherin interaction as a result of high 
cell density, the kinase initiates a series of phosphorylation events that ultimately 
phosphorylates YAP/TAZ, excluding them from the nucleus and decreasing 
proliferation.  (Image from Knippschild et al., 2014). 
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cadherin does not, suggesting that β-catenin/E-cadherin binding is necessary for this 
effect while E-cadherin homophilic binding is not (Sasaki et al., 2000).  Consistent with 
this, exogenous E-cadherin expression rescues proliferative control in epithelial cells 
that have undergone EMT, but the intracellular β-catenin binding domain is necessary 
for this effect (Stockinger et al., 2001).  β-catenin localization is a key determinant in 
carcinoma tumor cell characteristics, as nuclear β-catenin is associated with 
dedifferentiated, mesenchymal cells, while cytoplasmic and membranous β-catenin is 
typical of a more epithelial phenotype (Brabletz et al., 2001).  These findings indicate 
that the E-cadherin/β-catenin interaction is important in proliferative control, potentially 
by excluding β-catenin from the nucleus and preventing transcription of specific genes.  
Reports conflict however as to whether E-cadherin/β-catenin binding decreases β-
catenin transcriptional activity (Perrais et al., 2007; Stockinger et al., 2001).  Finally, 
both Hippo/MST and Wnt contribute to proliferative control, and there is interaction 
between these pathways through their member proteins, YAP/TAZ of Hippo/MST 
pathway and β-catenin of Wnt pathway.  When Hippo/MST is inactive and YAP/TAZ are 
cytosolic, YAP/TAZ interact with the upstream Wnt protein, disheveled (DVL), 
preventing its phosphorylation and subsequent Wnt signaling, or bind to the β-catenin 
destruction complex directly, excluding β-catenin from the nucleus (Imajo et al., 2012; 
Varelas et al., 2010).  Conversely, activation of Wnt releases YAP/TAZ from this 
complex, and facilitates nuclear translocation and transcription of target genes (Azzolin 
et al., 2014).  Thus, Hippo/MST activation discourages proliferation directly through 
nuclear exclusion of YAP/TAZ, and through inhibition of Wnt.  Wnt encourages 
proliferation directly by preventing degradation of and allowing for nuclear translocation 
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of β-catenin, and indirectly by releasing YAP/TAZ from the β-catenin destruction 
complex, thus encouraging nuclear translocation (see Fig. 2.7). 
 
 
 
 
 
Fig. 2.7: Crosstalk between the Hippo/MST and Wnt signaling pathways.  
Hippo/MST discourages proliferation directly through YAP/TAZ phosphorylation and 
nuclear exclusion (nucleus in gray), and indirectly through cytosolic YAP/TAZ 
inhibition of Wnt and β-catenin nuclear translocation.  Wnt encourages proliferation 
directly and indirectly by enabling nuclear translocation of β-catenin and YAP/TAZ, 
respectively. 
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2.2.5 Biophysical Forces and Confluent Proliferation 
Recent studies have demonstrated a new, canonical Hippo/MST independent 
contributor to proliferative control: biophysical force.  When cells proliferate in 
subconfluent conditions, mother cells divide, leaving two daughter cells with 
approximately half the area of the mother.  These daughter cells then undergo 
hypertrophic growth until they are approximately the same size as the mother cell and 
can divide again (Puliafito et al., 2012).  This process continues until contact with other 
cells is made, and is driven at least in part by biophysical forces experienced by cells 
due to hypertrophic and proliferative growth, extrusion, and locomotion.  Cells that are 
not surrounded by neighbors on all sides such as those in low confluency culture or at 
the periphery of a proliferating colony experience tensile force as they migrate away 
from the colony and are simultaneously pulled towards it by adhesion to neighbors 
(Puliafito et al., 2012).  Tensile force is known to promote nuclear localization of YAP 
and proliferation, and subconfluent cells subjected to stretching of the ECM proliferate 
at an increased rate and exhibit increased nuclear YAP percentage compared with 
controls (Aragona et al., 2013).  Conversely, cells within a confluent environment such 
as those in confluent monolayers or at the center of a proliferating colony experience 
inward constraining forces from neighbors and relief of tensile force, resulting in 
decreased nuclear YAP and proliferation rate.  LATS1/2 of the Hippo/MST pathway 
excludes YAP from the nucleus through phosphorylation at specific sites (Pan, 2010).  
Tensile relief from plating on a soft substrate decreases YAP/TAZ dependent 
transcription and nuclear localization, even in subconfluent conditions, in the absence of 
LATS1/2, or upon expression of LATS1/2 insensitive YAP, suggesting a Hippo/MST 
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independent mechanism (Aragona et al., 2013; Dupont et al., 2011).  Similarly, 
proliferation and nuclear YAP/TAZ percentage progressively decrease as cells are 
plated on patterned substrates of decreasing area, and both ROCK (Rho-associated 
protein kinase) and YAP/TAZ are necessary for this effect (Dupont et al., 2011).  Tensile 
relief via treatment with the Rho inhibitor, C3, ROCK inhibitor, Y27632, non-muscle 
myosin inhibitor, blebbistatin, or cytoskeletal inhibitor, latrunculin A, increase YAP/TAZ 
nuclear exclusion and decrease YAP/TAZ dependent transcription.  Tensile restoration 
by siRNA KD of F-actin capping and severing proteins is sufficient to restore 
proliferative capacity and nuclear YAP localization, even on soft substrate or under 
dense plating conditions (Aragona et al., 2013).  Taken together, these studies indicate 
that biophysical forces are sufficient for YAP/TAZ regulation and act in a Hippo/MST 
pathway, MST1/2 and LATS 1/2 independent manner.  
Finally, cells do not become proliferatively quiescent immediately following cell-
cell contact, but instead progress through additional rounds of confluent proliferation, 
which is size reductive in nature (Fig. 2.8, Aragona et al., 2013; Puliafito et al., 2012).  
Analysis of cell area following proliferation shows that newly divided cells in confluent 
environments do not decrease the area of existing cells, suggesting that they are not 
compressible.  However, the constraint exerted by neighboring cells restricts normal 
post-proliferative hypertrophic growth on newly divided cells, resulting in size reductive 
proliferation.  As cell area decreases due to successive divisions, a critical cell area is 
eventually reached below which proliferation is dramatically reduced.  This is known as 
the transition point, and is marked by a sudden, dramatic decrease in proliferative rate 
leading to CIP (Puliafito et al., 2012).  As previously noted, evidence suggests that the 
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gradual reduction in tension and increase in constraining force as confluency increases 
excludes YAP from the nucleus independent of Hippo/MST, and is a major contributor 
to CIP. These findings affirm the existence of confluent, size reductive division, and 
suggest that CIP is a complex behavior that is mediated in part by cell density through 
evolving biophysical forces.  As reviewed in the previous sections, AJC proteins play an 
important role in cell-cell interactions, junctional assembly, and proliferation control, and 
despite recent milestone advances in determining the mechanism of cell packing, it 
remains unknown what, if any, influence AJC proteins have in this process.  The current 
dissertation examines cell packing and monolayer maturation, and describes for the first 
time a specific role for occludin phosphorylation in facilitating these processes.  Results 
presented in the following chapters add to our understanding of monolayer maturation, 
and to the increasingly diverse cellular role of the AJC.   
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Fig. 2.8: Schematic of size reductive proliferation in MDCK cells.  MDCK cells go 
through a process known as cell packing at high confluency, which is characterized 
by size reductive proliferation and regulated at least in part by biophysical force.  (A) 
Subconfluent mother cells divide, yielding two daughter cells of approximately 50% 
size compared to the mother.  The daughter cells then attain the size of the original 
mother through hypertrophic growth.  (B) Following many rounds of subconfluent 
proliferation, increasing confluency leads to constraining force from adjacent cells.  
This inhibits hypertrophic growth following proliferation, leading to a 50% reduction in 
cell area at each division.  This is termed size reductive proliferation.  Ultimately, a 
critical cell area known as the transition point is reached, after which proliferation 
dramatically decreases, leading to quiescence.  (C) Tension on an individual cell 
(asterisk) from simultaneous migration away from neighboring cells and adherence to 
them induces proliferation (Aragona et al., 2013).  Constraint from neighboring cells 
at high confluency relieves this tension, and decreases proliferation.  (D) As cells 
proliferate and become increasingly confluent, cell area and tension decrease, while 
constraint increases, leading to size reductive proliferation, cell packing, and 
ultimately, to proliferative quiescence. 
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CHAPTER III 
 
Occludin S471 phosphorylation contributes to tight junction formation and cell 
packing at confluence1 
 
3.1 Abstract 
Multiple organ systems require epithelial barriers for normal function, and barrier 
loss is a hallmark of diseases ranging from inflammation to epithelial cancers.  
However, the molecular processes regulating epithelial barrier maturation are not fully 
elucidated. After contact, epithelial cells undergo cell packing and tight junction 
maturation creating a dense, highly ordered monolayer with high resistance barriers.  
We provide evidence that the tight junction protein, occludin, contributes to regulation of 
epithelial packing upon phosphorylation of S471 in its coiled-coil domain.  
Overexpression of an occludin S471A mutant that cannot be phosphorylated prevents 
cell packing, proper tight junction protein localization, and electrical resistance in a 
dominant manner.  Inhibition of cell proliferation in confluent but immature monolayers 
recapitulated this phenotype.  A kinase screen identified G-protein coupled receptor 
kinases (GRK) as S471 kinases, and GRK inhibitors delayed epithelial packing and 
junction maturation.  We conclude that cell packing is necessary for barrier maturation, 
and that occludin contributes to these processes in a phosphosite specific manner. 
 
3.2 Introduction 
                                                          
1
 Portions of this chapter are published in Bolinger et al., 2016.  Molecular and Cellular Biology. 
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Cells characteristically form epithelial monolayers through logarithmic growth 
when subconfluent followed by cell to cell contact, and concluding with contact inhibition 
of proliferation (CIP), proliferative quiescence, and epithelial monolayer maturation 
including tight junction (TJ) formation (Li et al., 2004; Puliafito et al., 2012).  CIP is an 
important step in monolayer maturation that is mediated in part by activation of the 
Hippo/MST pathway.  Hippo/MST involves a signaling cascade with multiple 
mechanisms of regulation that may be initiated by homophilic interactions between extra 
cellular domains of the adherens junction (AJ) protein E-cadherin on adjacent cells, 
ultimately leading to exclusion of the transcriptional co-activator, Yes–associated protein 
(YAP), from the nucleus (Kim et al., 2011; Levine et al., 1965). 
Puliafito et al. demonstrated however that cell-cell contact is not sufficient for CIP 
in Madin Darby canine kidney (MDCK) epithelial cells.  In fact, proliferation continues at 
a near subconfluent rate even in confluent cells until a critical cell density, or transition 
point, is reached, after which proliferation diminishes until cells reach quiescence (Adam 
et al., 1982; Puliafito et al., 2012).  Proliferation in confluent cells is accompanied by 
little or no hypertrophic growth. While subconfluent daughter cells ultimately attain 
nearly 100% of mother cell area, confluent cells remain at around 50%, indicating a 
nearly complete lack of hypertrophic growth in the densely confluent monolayer, 
consistent with the previously identified inverse relationship between individual cell size 
and density (Erlinger and Saier, 1982; Puliafito et al., 2012).  This reduction in cell size 
acts as the major activator of YAP nuclear exclusion through reduction of cytoskeletal 
stress (Aragona et al., 2013; Rauskolb et al., 2014, see section 2.2.5).  Indeed, forced 
reduction in cell size by growth on micropatterned fibronectin islands of defined area or 
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growth in a soft agar, to reduce cytoskeletal tension, leads to YAP nuclear exclusion in 
a manner dependent on F-actin capping/severing proteins but independent of cell 
contact (Aragona et al., 2013).  Thus, subconfluent cells are subject to tensile forces on 
the cytoskeleton that, combined with lack of cell contact, promote YAP nuclear 
localization and proliferation (Aragona et al., 2013; Rauskolb et al., 2014; Trepat et al., 
2009).  Confluent, pre-transition point epithelial cells, while contacted, also maintain 
YAP nuclear localization due to continued cytoskeletal tension, promoting proliferation. 
However, the cells are exposed to constraining forces that discourage post-mitotic 
hypertrophic growth causing a period of size reductive proliferation ultimately reducing 
cytoskeletal stress and transitioning the cells to proliferative quiescence and finally 
monolayer maturation (Puliafito et al., 2012). This process sharply decreases cell area 
and increases cell density, resulting in increased uniformity of cell area and shape, and 
establishes a mature, packed, epithelial monolayer.  
A mature epithelial monolayer possesses well-developed TJs, which are 
necessary to control fluid and solute flux.  TJs form between adjacent cells apical to the 
AJ and create and maintain semi-permeable barriers to paracellular flux, and may 
contribute to maintaining cell polarity.  Over 40 proteins have been identified at TJs 
(Anderson and Van Itallie, 2009) including occludin, the first transmembrane TJ protein 
to be discovered (Furuse et al., 1993).  While occludin knockout mice failed to exhibit 
any increase in intestinal permeability, these animals presented with a constellation of 
complex phenotypes consistent with barrier dysregulation including male sterility, 
inability to nurse, and brain calcification (Saitou et al., 2000; Schulzke et al., 2005).  
Human patients expressing a recessive mutation in the occludin gene exhibit similar 
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brain calcification, as well as gross cranial malformation (O'Driscoll et al., 2010).  Taken 
together, these studies support the prevailing view of occludin as a regulator of the TJ. 
Recently, occludin has been increasingly implicated in non-barrier roles including 
regulation of cell proliferation.  Occludin is present at centrosomes and regulates mitotic 
entry and cell proliferation in a phosphorylation dependent manner (Runkle et al., 2011).  
Occludin knockout mice exhibit intestinal cell hyperplasia (Saitou et al., 2000), and 
occludin down-regulation or loss has been implicated in cancers of the skin (Rachow et 
al., 2013), uterus (Tobioka et al., 2004) and breast (Martin et al., 2010), and is 
correlated with increased metastatic potential (Osanai et al., 2006).  Furthermore, 
occludin re-expression rescues murine tumorigenesis after implantation of oncogenic, 
Raf1-transformed cells (Wang et al., 2005).  The emerging importance of occludin in 
regulating cell proliferation suggests a role for occludin in cell packing. 
Mass spectrometric analysis has identified several novel occludin 
phosphorylation sites, including the S471 site within the C-terminal coiled-coil domain 
(Sundstrom et al., 2009).  Notably, this residue is located at the first turn of the coiled-
coil, which has been established as an interaction point with the scaffolding protein, 
zonula occludens-1 (ZO-1, (Tash et al., 2012).  ZO-1 interacts with and organizes many 
TJ proteins, and links the junction to the actin cytoskeleton (Lye et al., 2010), and 
members of the ZO family are necessary for assembly of TJs (Rodgers et al., 2013; 
Umeda et al., 2006).  ZO-1 is a membrane associated guanylate kinase (MAGUK) 
protein and contains the typical catalytically inactive guanylate kinase (GuK) like 
domain. The GuK domain acts as a specialized P-serine/P-threonine binding pocket 
(Zhu et al., 2011), and the ZO-1 GuK domain interacts with the acidic head of the 
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occludin coiled-coil, including the S471 site, making it an intriguing site for potential 
functional regulation and further analysis (Tash et al., 2012).  
In the current study, we present evidence that expression of occludin 
phosphoinhibitory mutant S471A prevents size-reductive proliferation and cell packing 
in MDCK cells.  Expression of S471A has no effect on sub-confluent proliferation, but 
inhibits size reductive proliferation after contact and prevents bicellular and tricellular TJ 
maturation, creating a highly permeable monolayer that appears morphologically 
indistinguishable from an immature monolayer before cell packing.  Furthermore, 
inhibition of cell cycle progression after cell contact yields a similar, immature 
monolayer, suggesting that cell packing is necessary for monolayer maturation and TJ 
formation.  The S471 site is a target of members of the G-protein coupled receptor 
kinase (GRK) family, and inhibition of GRK 4-6 also inhibits size reductive proliferation 
and delays epithelial cell maturation. Further, the effect of the GRK inhibitors on 
monolayer maturation can be overcome by expression of the phosphomimetic S471D 
occludin.  The data suggest that occludin phosphorylation at S471 contributes to control 
of size reductive proliferation after contact, and to epithelial maturation.  
 
3.3 Methods 
Cells 
All reagents were purchased from Sigma Chemical (St. Louis, MO) unless 
otherwise noted.  Madin Darby canine kidney (MDCK) cells were obtained from 
American Type Culture Collection (Manassas, VA) and cultured in minimum essential 
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media as previously reported (Runkle et al., 2011).  All cells were kept at 37°C with 5% 
CO2. 
MDCK stable lines were generated via transfection with lipofectamine 2000 
(Invitrogen, Carlsbad, CA) of empty vector, wild type human occludin, S471A mutant 
occludin, or S471D mutant occludin in a pmaxFP expression vector (Amaxa, Cologne, 
Germany) following manufacturer instructions and as previously described (Shen and 
Turner, 2005).  Briefly, fluorescence-activated cell sorting was carried out following 2 
weeks of culture in normal MEM with 2.5 mg/ml geneticin (Gibco, Carlsbad, CA).  Single 
cells were plated in a 96-well plate with 2.5 µl/ml geneticin, grown out, and screened for 
GFP expression by western blot.  W2, A3, and D2 lines were used unless otherwise 
indicated (Fig. 3.1).  All reported experiments were repeated on separate days except 
for Fig. 3.4, which represents multiple platings.  Cells were plated at a density of 
162,500 cells/cm2 unless otherwise noted. 
 Immunofluorescence (IF) 
 Cells were plated on chambered glass slides and fixed at 4 days post confluent 
unless otherwise noted with either 3.5% paraformaldehyde (PFA) for 10 minutes or 50% 
methanol/50% acetone for 20 minutes at -20°C (Thermo Scientific, Waltham, MA).  PFA 
fixation was followed by 15 minutes permeabilization in TBS plus 0.25% triton-x 100 
while methanol/acetone fixation did not require permeabilization.  Cells were blocked in 
10% goat serum (Life Technologies, Carlsbad, CA) with 0.25% triton-x 100 for 1 hour, 
then stained with indicated primary antibodies overnight at 4°C and 1:200 dilution in 
blocking solution, except for anti-turbo GFP (1:400, Evrogen, Moscow, Russia) and anti-
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YAP (1:100, Santa Cruz, Dallas, TX).  Secondary antibody (Alexa Fluor 488, 555, and 
647, Life Technologies, Carlsbad, CA) exposure was 1 hour at room temperature in 
blocking buffer at a 1:1,000 dilution.  Fluorescence was determined from Z-stacks of 0.5 
µm slices taken on a Leica TCS SP5 confocal microscope (63x, 1.4 N.A oil objective, 
Wetzlar, Germany) with photomultiplier tube detectors, and using Leica Advanced 
Fluorescence software.  Images were analyzed using Metamorph software (Molecular 
Devices, Sunnyvale, CA). In some cases, occludin and ZO-1 border staining was 
quantified by a semi-quantitative ranking score system based on a scale of 1 to 5: 1 for 
near complete loss of border staining (0-25%), 2 for 25-50% continuous border staining, 
3 for 50-75% continuous border staining, 4 for 75-100% continuous border staining, and 
5 for completely continuous border staining. Scoring was completed in a masked 
fashion by 3 impartial observers provided scoring standard images for comparison. 
Adherens junction/cell height 
Fixation was performed using 1:1 methanol/acetone or 3.5% PFA as previously 
described (AJ area), or 3.5% PFA in the absence of permeabilization (cell height).  Area 
within E-cadherin border staining was determined from multiple 63x - 1x zoom confocal 
images using Metamorph software (Molecular Devices, Sunnyvale, CA).  Cell height 
was determined from 63x - 1x zoom XZ confocal images of plasma membrane staining 
and Leica Advanced Fluorescence software (Wetzlar, Germany). 
Cell counts 
Nuclei were counted from monolayers stained with either Hoechst or PicoGreen 
nuclear stain (Life Technologies, Carlsbad, CA) using the ImageJ cell counter plugin 
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(NIH, Bethesda, MD).  At least four microscopy fields were averaged for each cell line or 
treatment (63x objective, 5x zoom).  1,400 cells/cm2 were also plated on 12 well plates, 
then trypsinized and counted at 1, 2, 3, and 4 days post-plating using a Mo-FLO cell 
sorter (Beckman Coulter, Brea, CA).  Forward scatter data was collected to determine 
suspended cell size, and exhausted cell media from each time point was saved for 
quantification of floating cells. 
DNA synthesis/cell proliferation assays 
7,857, 100,000, or 185,714 cells/cm2 were plated on eight chambered glass 
slides (Thermo Scientific, Waltham, MA) and allowed to grow overnight (7,857 and 
100,000 cells/cm2) or for 4 hours (185,714 cells/cm2).  Cells were incubated with 10 µM 
EdU (Click-It EdU kit, Life Technologies, Carlsbad, CA) for 4 (7,857 and 100,000 
cells/cm2) or 24 (185,714 cells/cm2) hours according to manufacturer instructions.  Cells 
were fixed with 3.5% PFA and stained with Hoechst or PicoGreen nuclear stain 
(Invitrogen, Carlsbad, CA).  At least 500 cells per condition were examined using the 
ImageJ cell counter plugin (NIH, Bethesda, MD), and percentage of total cells 
expressing EdU was calculated. 
Trans-epithelial resistance (TER) 
TER was determined using the electric cell-substrate impedance sensing (ECIS, 
Applied Biophysics, Troy, NY) system at 500 Hz.  Cells were plated on 8W10E+ ECIS 
plates and allowed to become confluent overnight.  All treatments were added at the 
time of plating and replenished along with fresh media every 24 hours unless otherwise 
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noted.  Electrical resistance was determined on the fourth day post-confluence unless 
otherwise noted. 
Solute flux assay 
Cells were plated on 12-well plates with polyester transwell inserts (0.4 µM pore, 
Corning, Corning, NY) and allowed to become confluent overnight.  Solute flux was 
determined on the fourth day post-confluence as previously described (Phillips et al., 
2008).  Briefly, 480 nM TAMRA (467 Da) was added to the apical chamber followed by 
sampling of 50 µL from the basolateral chamber every 30 minutes for 3 hours.  10 µL 
was also removed from the apical chamber at the last time point for apical concentration 
determination.  Fluorescence was measured (ex. 560, em. 590) in a flat bottom black 
wall 96-well plate (Greiner, Monroe, NC) using a FLUOstar microplate reader (BMG 
Labtech, Ortenburg, Germany).   
Cell cycle inhibitor assays 
Cells were treated with 10 µM roscovitine (Calbiochem, San Diego, CA) 24 hours 
after plating, and drug was replenished along with fresh media every 24 hours.  TER 
measurements proceeded for two additional days (from 24-72 hours post plating using 
ECIS system), or cells were fixed for imaging at 60h post plating. 
Determination of protein expression and immunoprecipitation experiments  
Protein expression was determined via western blot as previously described 
(Phillips et al., 2008).  Briefly, MDCK cells were harvested in Stuart’s Buffer composed 
of 100 mM NaCl, 1% triton-x 100, 0.5% sodium deoxycholate, 0.2% SDS, 2 mM EDTA, 
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10 mM HEPES (pH 7.5), 1 mM NaVO4, 10 mM NaF, 10 mM sodium pyrophosphate, 1 
mM benzamidine, 10 μM microcystin (Cayman Chemical, Ann Arbor, MI), and complete 
mini protease inhibitor tablet (EDTA free, Roche, Indianapolis, IN).  Following gel 
electrophoresis and blocking in 2% ECL prime (GE Healthcare, Little Chalfont, 
Buckinghamshire, UK), proteins were probed with indicated antibodies including 
occludin, claudin-1, and tricellulin (Invitrogen, Carlsbad, CA), β-catenin and afadin 
(Sigma, St. Louis, MO), turboGFP (Evrogen, Moscow, Russia), ZO-1 and GRK 
(Millipore, Billerica, MA), and E-cadherin (BD Biosciences, Franklin Lakes, NJ).  
Alternatively, MDCK cells were harvested for immunoprecipitation as previously 
described (Titchenell et al., 2012) in buffer containing 50 mM Tris (pH 7.5), 150 mM 
NaCl, 1% NP-40 (USB, Cleveland, OH), 1 mM NaVO4, 10 mM NaF, 10 mM sodium 
pyrophosphate, 1 mM benzamidine, complete mini protease inhibitor tablet (EDTA free, 
Roche, Indianapolis, IN), 1 μM microcystin (Cayman Chemical, Ann Arbor, MI), 10% 
glycerol (Fisher, Waltham, MA) and 2 mM EDTA (Lonza, Walkersville, MD).  Following 
harvest, cells were rocked for 15 minutes and spun at 12,000 g for 10 minutes.  Lysate 
containing 1 mg of protein was pre-cleared with 30 µl packed volume protein G 
sepharose beads (GE Healthcare, Little Chalfont, Buckinghamshire, UK), then 
incubated overnight with 10 μg turboGFP antibody (Evrogen, Moscow, Russia).  Protein 
G beads were added to the antibody and lysate mix for one hour, then washed with 
buffer and prepared for western blotting as previously described. 
Co-culture experiments 
Subconfluent parental MDCK cells were transduced with Cell-Light mitochondria 
BacMam baculovirus (Invitrogen, Carlsbad, CA).  The next day, transduced parental 
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MDCK were plated with untransduced S471 Occ cells at a ratio of 10%/90%, 
respectively.  Cells were fixed in PFA and prepared for IF as previously described. 
Cell cycle stage measurements 
Four day- post confluent cells were stained in suspension with Hoechst, which 
was then quantified using an LSR II flow cytometer (Becton Dickinson, Franklin Lakes, 
NJ).  Cell cycle stage was determined by amount of nuclear material present.  
Ion permeability 
97,500 cells were plated on Biopore cell culture inserts (0.4 µm pore, Millipore, 
Billerica, MA) with fresh MDCK media provided daily.  On the fourth day post 
confluence, inserts were loaded into an Ussing chamber (Harvard Apparatus, Holliston, 
MA), and both sides were gently filled with HEPES ringer solution composed of 135 mM 
NaCl, 5 mM KCl, 10 mM HEPES, 10 mM glucose, 1.8 mM CaCl2, and 1 mM MgCl2.  
Permeability to specific ions was determined by voltage or current clamp (EC-800 
amplifier, Warner Instruments, Hamden, CT) recordings collected in the presence of 
ringers with the NaCl or KCl concentration in the apical chamber reduced by 75% 
(33.75 mM NaCl, 1.25 mM KCl), and original osmolarity restored by mannitol addition.  
Ion permeability ratio was calculated using the Goldman-Hodgkin-Katz equation: 
η = – (ε – ev) / (1 – ε ev). 
 where η is the ratio of permeability of the monolayer to Na+ over the permeability to Cl– 
(η = PNa/PCl ), ε is the dilution factor (ε = Cbasal/Capical), and v = eV/kT (V is the dilution 
potential, k is the Boltzmann constant, e is the elementary charge and T is the 
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temperature in Kelvins).  Absolute permeability of sodium and chloride was calculated 
using the simplified Kimizuka-Koketsu equation: 
PNa = (G / C) * (RT / F
2) * (η / (1 + η)) 
PCl = (G / C) * (RT / F
2) * (1 / (1 + η)), 
where G is the total membrane conductance calculated using Ohm’s law (V = I*R or G = 
I/V), C is the concentration of ion in solution, R is the gas constant, F is Faraday’s 
constant, and η is the ratio of permeability of the monolayer to Na+ over the permeability 
of Na+ to Cl–.  All experiments were conducted at room temperature.   
Cell viability 
Cell viability was determined using a WST-1 assay (Roche, Indianapolis, IN). 
31,250 cells/cm2 were plated in a 96 well plate, allowed to grow overnight, then 
incubated with 5 µl WST-1 reagent for 1 hour.  Absorbance was measured (770/410 
nm) using a FLUOstar microplate reader (BMG Labtech, Ortenburg, Germany). 
Statistical analysis 
Data were analyzed using two-tailed student’s t-test (2 groups), or one-way 
ANOVA with Bonferroni post hoc (3 or more groups) using Prism 5.0 (GraphPad 
Software, La Jolla, CA).  Line graphs were analyzed using a two-way ANOVA (simple 
effect within rows) with Bonferroni post hoc.  Data are expressed as mean ± SD unless 
otherwise indicated. 
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3.4 Results 
S471A Occ expression compromises TJ protein organization. 
MDCK lines overexpressing human occludin with a phosphoinhibitory serine to 
alanine (S471A) or phosphomimetic serine to aspartic acid (S471D) mutation were 
generated along with wild type occludin (WT Occ) control lines to investigate the effect 
of S471 phosphorylation on TJ protein organization (Fig. 3.1 A and B).  Both exogenous 
GFP tagged occludin (80 kD) and endogenous (55kD) occludin were detectable by 
western blot, and no appreciable changes were observed in expression of any tested TJ 
or AJ proteins in lines utilized for the current study (Fig. 3.1 C).  
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Fig. 3.1: Stable MDCK lines have similar tight junction expression.  (A) Schematic 
of occludin with S471 site (yellow dot) and (B) fusion protein construct with mutations 
used for stable expression in MDCK cell lines.  (C) Western blots for indicated TJ and AJ 
proteins. P=Parental, EV=Empty vector, W1-2=WT Occ clones 1 and 2, A1-3=S471A 
Occ clones 1-3, D1-2=S471D Occ clones 1 and 2.  Arrows indicate exogenous GFP-
occludin (black), exogenous occludin (red), and GFP (green). All molecular markers are 
given in kD. W2, A3, and D2 lines were used unless otherwise indicated. 
CMV 
Promoter 
GFP Human 
Occludin 
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Cells expressing WT Occ had well-organized localization at the border for the TJ 
proteins occludin (GFP-occludin and total occludin), ZO-1, and claudin-1 based on 
immunofluorescence (IF) labeling (Fig. 3.2 A).  Additionally, tricellulin appeared at tTJs.  
Phalloidin staining for F-actin revealed stress fibers basolaterally and crisp cortical actin 
staining apically, while afadin was present at the border (Fig. 3.2 B).  Finally, the AJ 
proteins E-cadherin and β-catenin demonstrated strong cell border organization (Fig. 
3.2 C).  All results were consistent with known localization of these proteins in cells with 
high electrical resistance and low solute permeability.  S471D Occ expressing cells 
were similar in their staining pattern to control lines, and in many cases were 
qualitatively better organized with increased uniformity in cell shape, and brighter, more 
focused border staining, particularly in regards to cortical F-actin (Fig. 3.2 A-C).  In 
contrast, TJs were disorganized in S471A Occ lines with mislocalized or missing border 
staining in all examined TJ proteins. These studies were performed on day 4 after 
plating, and the TJ disorganization was maintained for at least 10 days after plating 
(data not shown).  The TJ proteins occludin, ZO-1 and claudin-1 appeared as non-
continuous aggregates, often co-localizing with each other, while tricellulin staining was 
largely absent (Fig. 3.2 A).  Expression of S471A Occ did not, however, decrease the 
occludin-ZO-1 interaction as judged by co-immunoprecipitation experiments (Fig. 3.3 A) 
or alter endocytosis as assessed by colocalization with early endosome antigen 1 
(endosome marker, Fig. 3.3 B), nor was there evidence that S471A mutant cells 
corrupted neighboring parental cell TJ organization (Fig. 3.3 C), suggesting a cell 
autonomous effect.  The cell cycle stage of proliferatively quiescent WT, S471A, and 
S471D Occ lines were also similar, indicating that the mutations do not cause arrest in a 
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non G1/G0 cell cycle stage (Fig. 3.3 D-E).  By contrast, F-actin staining was altered with 
fewer visible stress fibers and dim, broad, cortical actin organization.  Afadin was also 
disorganized or lost at bicellular junctions (Fig. 3.2 B), but importantly, the AJ proteins 
E-cadherin and β-catenin appeared unaffected (Fig. 3.2 C).  To quantify the extent of 
ZO-1 protein mislocalization, co-localization between ZO-1, a marker of TJ organization, 
and E-cadherin, an AJ protein unaffected by S471A Occ expression, was 
measured.  The percent of E-cadherin colocalized with ZO-1 (indicating ZO-1 border 
staining) was significantly decreased in S471A Occ lines and increased in S471D Occ 
lines compared with WT Occ (Fig. 3.2 D and E).  Together, these observations 
demonstrate that expression of S471A Occ compromises TJ organization in a dominant 
manner. 
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Fig. 3.2: Tight junction and cytoskeletal proteins are mislocalized in occludin 
S471A mutant cell lines. (A-C) Immunofluorescent maximum projected stacks (3 
μm thick) or slices (phalloidin images, 0.5 μm thick) of indicated (A) TJ, (B) 
cytoskeletal staining and afadin, and (C) AJ proteins (scale bar = 10 μm). (D) 
Maximum projected colocalization of E-cadherin, used as a marker of junctional 
complex, with ZO-1 demonstrating loss of ZO-1 at junctions (scale bar = 50 μm). (E) 
Quantification of D (average of 4 images per cell line). Data are expressed as Mean 
± SD. *P<0.05 compared to WT Occ or S471D Occ. 
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TJ formation occurs during size reductive proliferation. 
As detailed in the introduction, size reductive proliferation is required for 
monolayer maturation. Here, the formation of TJs was examined across size reductive 
proliferation and epithelial maturation.  MDCK cells were plated on 8 chambered slides 
at 162,500 cells/cm2 (yielding confluency on the first day of plating).  The cells 
underwent dramatic morphologic changes associated with size reductive proliferation in 
the first three days following confluency.  Cell density increased by over 2-fold as 
indicated by nuclei counts (Fig. 3.4 A and B).  Meanwhile, the AJs were partially 
completed by day 1 and largely formed by day 2, and area within the AJ decreased by 
half by day 3 (Fig. 3.4 C and D). Finally, TJ assembly assessed by ZO-1 staining was 
largely incomplete on day 1, but increased dramatically over days 2 and 3 such that 
colocalization with E-cadherin increased, indicating increased ZO-1 border localization 
(Fig. 3.4 E and F).  Packing was complete by three days post confluency for each of the 
measured parameters, and no statistically significant changes occurred between days 3 
and 4. The TJ organization observed in the S471A expressing lines appeared highly 
Fig. 3.3: S471 lines co-immunoprecipitation, colocalization and co-cultures. (A) 
Protein ratio of co-immunoprecipitated GFP-occludin and ZO-1 proteins, normalized to 
WT Occ protein ratio (n=5-6). (B) Colocalization of GFP-occludin and endosomal marker 
EEA1 including Pearson’s, Mander’s A (percent of EEA1 colocalizes with GFP), and 
Mander’s B (percent of GFP that colocalizes with EEA1), average of 3-5 images per 
condition). (C) Parental cells labeled with Cell Light mitochondria BacMam baculovirus 
(red), co-cultured with GFP-tagged S471A Occ lines (green), and stained for ZO-1(faux 
colored in white). Left, merged image, right ZO-1 alone, arrows indicating intact parental-
parental (white) and disrupted S471A-S471A (yellow) borders.  (D) Schematic of DAPI 
fluorescence intensity as an indicator of cell cycle (adapted from Henderson et al., 
2013). (E) Fluorescence intensity of WT Occ (green), S471A (orange), S471D (blue), 
and unstained parental MDCK (red) cells stained with DAPI. Data are expressed as 
Mean ± SD, *P<0.05 compared to WT Occ. 
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similar to the early time point in epithelial maturation; therefore, cell size and 
proliferation were examined in the mutant lines.    
 
 
 
 
Fig. 3.4: MDCK cells exhibit size reductive proliferation and TJ organization. High 
density plating followed by measurements of cell number, size, and junctional 
organization, 1-4 days post confluent of (A, B) nuclei (DAPI), (C, D) E-cadherin IF and 
area within AJ, and (E,F) ZO-1 IF and maximum projected E-cadherin colocalization as 
a measure of ZO-1 border continuity and TJ assembly (scale bar: 10 μm). Data are 
expressed as Mean ± SD (average of 4 images per condition). *P<0.05 compared to 1 
day post confluent. 
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Size reductive proliferation is attenuated by S471A Occ expression. 
Cell monolayers expressing S471A Occ were composed of fewer and larger cells 
than WT Occ or S471D Occ monolayers (Fig. 3.5 A-C).  Nuclei number was 
approximately half compared to cells expressing WT Occ or S471D, and the area within 
the AJ (E-cadherin staining) was increased in S471A Occ confluent monolayers by 2 to 
4-fold compared to WT Occ or S471D Occ lines (Fig. 3.5 A and B).  Cell height was not 
different however, suggesting an increase in cell volume in S471A Occ lines compared 
to WT Occ and S471D (Fig. 3.5 D).  To determine if S471A mutants altered cell 
proliferation or size in suspension, cells were plated at low density (1,400 cells/cm2) and 
counted following trypsinization on days 2-4.  S471A cell size in suspension was not 
different from WT Occ, indicating a strictly adherent cell effect (Fig. 3.5 E).  Adherent 
cell number, as determined by flow analysis, was reduced in S471A Occ monolayers at 
higher confluences on days 3 and 4, but not on days 1 or 2 when confluency was low 
and there was little cell contact, suggesting loss of proliferation in a density dependent 
manner (Fig. 3.5 F). Non-adherent cells were counted to eliminate the possibility of 
increased cell extrusion in S471A Occ lines, and no difference was observed between 
any of the lines (Fig. 3.5 G).  Finally, the nearby Y474 site participates in PI3K activation 
(Du et al., 2010), and its proximity to S471 represents a possible mechanism for 
proliferative differences amongst the mutants.  Tyrosine phosphorylation of GFP-Occ 
from various S471 mutant lines was similar however, indicating that the use a Y474 
phospho-specific antibody or other phosphorylation detection method that is Y474 
specific may be necessary to evaluate this possibility (Fig. 3.5 H).   
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To examine the possibility of a density dependent decrease in S471A Occ 
proliferation, we measured the proliferative rate of WT Occ, S471A Occ, and S471D 
Occ lines at various confluences by DNA synthesis measurements (Click-IT EdU).  At 
7,857 (~10% confluent) and 100,000 (~55% confluent) cells/cm2, the number of cells 
with active DNA synthesis was measured over a 4h period whereas when plating 
185,714 (~100% confluent) cells/cm2, the number of synthetically active cells was 
measured over 24h since the rate of overall synthesis dramatically slows as cells 
become more confluent.  No difference in proliferation was observed at low confluence 
(Fig. 3.6 A), but became increasingly evident with increasing confluence (Fig. 3.6 B-C).  
When plated at ~ 100% confluence, fewer than 10% as many S471A Occ cells 
proliferated over the 24 hours (4-28 hours post plating) compared with WT Occ, while 
there was no difference between WT Occ and S471D Occ (Fig. 3.6 C).  The proliferative 
rate was near zero in all cell lines from 28-52 hours post plating (Fig. 3.6 D), suggesting 
that when plated at high confluency, proliferation is restricted in MDCK to a size 
reductive or packing phase lasting no longer than 24 hours, followed by relative 
quiescence.  However, expression of S471A Occ inhibits this packing phase.  The 
transcriptional co-activator, YAP, promotes cell proliferation in the nucleus, and its 
Fig. 3.5: Phosphoinhibitory (S471A) monolayers are composed of fewer, larger 
cells than controls. (A) Quantification of nuclei/mm2 in various lines. (B) 
Quantification of area within AJ (E-cadherin staining) and (C) representative images 
(scale bar: 10 μm). (D) Average cell height.  (E) Average suspended cell size at 2-4 
days post confluent and (F) cell counts by flow cytometry 2, 3, or 4 days post plating.  
(G) Floating (extruded) cell counts 2-4 days post confluent.  Floating cells were 
allowed to accumulate for 24 hours prior to counting.  (H) Tyrosine phosphorylation 
of various lines following GFP-Occludin IP and pY20 IB.  Data are expressed as 
mean ± SD, A-B and D represent the average of 4 images per condition, E-F, G-H 
represent average of 3 experiments). *P<0.05 compared to WT Occ or S471D Occ. 
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nuclear exclusion marks the end of the Hippo/MST signaling pathway and contributes to 
CIP (Gumbiner and Kim, 2014).  Despite proliferative quiescence, YAP localization 
remained nuclear in S471A Occ lines compared to WT Occ at quiescence, consistent 
with the S471A mutant stalling size reductive proliferation, and preventing YAP nuclear 
exclusion (Fig. 3.6 E-F).  Taken all together, these results indicate that size reductive 
proliferation is deficient in S471A Occ lines, and raises the possibility of a connection 
between defective packing and poor TJ assembly (Fig 3.2 A). 
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Cell packing is necessary for barrier assembly. 
To evaluate the necessity of cell packing alone for barrier assembly, we treated 
parental MDCK with the Cdk inhibitor, roscovitine, starting at 24 hours post plating to 
halt the cell cycle and size reductive proliferation.  Nuclei number was decreased (Fig. 
3.7 A) and area within the AJ was increased (Fig. 3.7 B) compared to controls, 
confirming that packing was significantly attenuated.  Trans-epithelial electrical 
resistance (TER) was decreased on day 3 (Fig. 3.7 C), and there was a significant loss 
of ZO-1 border staining compared with continuous E-cadherin staining (Fig. 3.7 D-E), 
indicating disorganization of TJ proteins at the border.  These studies demonstrate that 
inhibition of cell packing alone reduces TJ assembly and prevents high resistance 
barrier formation. 
Fig. 3.6: Proliferation after contact was inhibited in S471A Occ lines. (A-D) 
EdU labeling was measured at the indicated confluences as described in Methods, 
and percent of cells demonstrating DNA synthesis was quantified (at least 500 cells 
examined per cell line, per condition). (E) IF images of YAP localization in 
subconfluent and confluent WT Occ, and confluent S471A Occ lines (scale bar: 50 
μm, 10 μm for inset). (F) Quantification of percent nuclear YAP (average of 4 
images per condition). Data are expressed as Mean ± SD normalized to WT Occ. 
*P<0.05 compared to WT Occ. 
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Fig. 3.7: Inhibition of size reductive proliferation delays peak TER and 
mislocalizes TJ proteins. (A) Nuclei counts and (B) AJ area in day 3 post 
confluent MDCK monolayers demonstrating inhibition of size reductive 
proliferation following treatment with the cell cycle inhibitor, roscovitine, added at 
24h after plating. (C) TER of day 3 post confluent MDCK cells (n=10-11). (D) 
Representative images of ZO-1 (TJ marker) and E-cadherin (AJ marker) 
following treatment with roscovitine or DMSO control (scale bar: 50 μm). Yellow 
arrows highlight gaps in ZO-1. (E) Quantification of maximum projected 
colocalization of E-cadherin and ZO-1 as a measure of TJ organization. Data are 
expressed as Mean ± SD (average of 4 images per condition). *P<0.05 
compared to 0.5% DMSO. 
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S471A Occ compromises barrier function. 
A hallmark of epithelial sheets with well-formed TJ barriers is high TER.  To 
determine whether S471A Occ expression affected TER, measurements were 
conducted in multiple cell lines.  Loss of high resistance barriers was observed in 
S471A Occ expressing lines that had also shown stalled size reductive proliferation.  
WT Occ overexpression increased TER in mature (day 3, Fig. 3.8 A  and day 4, Fig. 3.8 
B) monolayers, as well as after 12 hours of reassembly following a Ca2+ switch 
experiment (Fig. 3.8 C) as previously reported (Balda et al., 1996; McCarthy et al., 
1996; Van Itallie et al., 2010).  No differences were evident between WT Occ and 
S471D Occ lines at any of the time points.  In contrast, S471A Occ expression reduced 
TER at all time points in all lines tested, and permeability to Ca2+, K+, and Cl- ions was 
uniformly increased in S471A Occ mutants (Fig. 3.8 D-F).  Permeability to the small 
fluorescent molecule tetramethylrhodamine (TAMRA, 467 Da) was also increased in 
S471A lines, and there was no difference between WT Occ, S471D, and parental lines 
(Fig. 3.8 G).  These results indicate an increase in permeability to both ion and small 
molecule flux in S471A Occ lines. 
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S471 is phosphorylated in vitro by G-protein coupled receptor kinase (GRK), and 
GRK inhibitors attenuate epithelial maturation. 
Fig. 3.8: Barrier permeability is increased in phosphoinhibitory S471A Occ 
lines compared to WT Occ or S471D. (A-C) Trans-epithelial electrical resistance 
(TER) 3 days (A) or 4 days (B) post confluence, or following 12 hours of recovery 
from a day 4 calcium switch experiment (C). (D-F) Ion permeability for (D) sodium, 
(E) potassium, and (F) chloride in parental and various S471 mutant MDCK lines. (G) 
Solute flux of TAMRA tracer (467 Da) 4 days post confluence. Data are expressed as 
Mean ± SD (n = 9-16 A-C, n= 9 D-F, n = 13-21 G). *P<0.05 compared to WT Occ (D-
F courtesy of Aniket Ramshekar). 
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Our previous studies suggest that S471 phosphorylation is important for cell 
packing and barrier formation.  To screen potential cellular kinases for this residue, 
putative kinases were identified using three kinase prediction software programs, and 
kinases predicted by at least two were screened against a 21 AA peptide with S471 at 
the center (Fig. 3.9, see methods).  This peptide was phosphorylated in vitro by 
members of the polo like kinase (PLK), calcium/calmodulin dependent kinase (CaMKII), 
and G protein coupled receptor kinase (GRK) families.  
Kinase screen 
A list of potential kinases was compiled by entering the sequence around S471 
(KELDDYREESEEYMAAADE) into three online kinase prediction programs: GPS (Xue 
et al., 2008), KinasePhos (Huang et al., 2005), and NetPhos (Blom et al., 
1999).  Kinases predicted to phosphorylate S471 by at least two of the three programs 
were included in an in vitro P32 kinase assay (Millipore, Dundee, Scotland, UK) of the 
same peptide with two added lysines at the amino terminus to promote peptide capture 
on nitrocellulose filters (KKKELDDYREESEEYMAAADE, NeoBioSci, Cambridge, MA).  
GRK identified in this screen was inhibited in MDCK cells using the kinase-specific 
inhibitors CCG215022 (GRK Inhib 22, Homan et al., 2015), 4-amino-5-(bromomethyl)-2-
methylpyrimidine hydrobromide (ABMH, Santa Cruz), and paroxetine (Toronto 
Research Chemicals, Toronto, ON, Canada).  Kinase assays with all three inhibitors 
were performed as previously reported (Homan et al., 2015).  
Kinase assays 
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GRK kinetic assays were conducted in a buffer containing 20 mM HEPES (pH 
7.0), 2 mM MgCl2, and 0.025% n-dodecyl–D-maltoside with 50 nM GRK and 500 nM 
tubulin in 5-minute reactions. Reactions were quenched with SDS loading buffer, 
separated via SDS-PAGE, dried, and exposed with a phosphoimaging screen prior to 
quantification via a Typhoon imager, as previously reported (Homan et al., 2015). Data 
were quantified using Image Quant and inhibition curves were then fit via GraphPad 
Prism with a three variable dose-inhibitor response curve with a fixed hill slope of 1. 
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Since GRK has previously been implicated in cell size control (Chakraborty et al., 
2014) and GRK isoforms were present in the MDCK cells, this kinase was targeted for 
cell packing and junction formation studies.  siRNAs to GRK were unsuccessful in 
knocking down protein levels despite multiple attempts (data not shown).  However, 
three chemically distinct pharmacological GRK inhibitors prevented epithelial 
maturation. GRK Inhib 22 (CCG215022), a potent GRK inhibitor (Homan et al., 2015), 
demonstrated inhibition of GRK6 with an IC50 of 0.95 ± 0.12 µM, while 4-amino-5-
(bromomethyl)-2-methylpyrimidine hydrobromide (ABMH) and paroxetine (Thal et al., 
2012) inhibited GRK6 with IC50s of 499 ± 144 µM and 78.80 ± 12.30 µM, respectively 
(Fig. 3.10 A).  
Fig. 3.9: S471 in vitro kinase screen. Phosphorylation of an S471-containing 21 
amino acid peptide by various kinases quantified via P32 incorporation. Peptide 
sequence is given with location of S471 (arrow). 
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Fig. 3.10: GRK inhibitor activities and effects on TER. (A) in vitro IC50s for GRK 
inhibitors. (B-D) Day 3 TER composite traces from ECIS measurements of various 
GRK inhibitors including (B) GRK inhibitor 22, (C) ABMH, and (D) paroxetine. Data 
are expressed as mean ± SD (n=6 A, n=4-8 B-D). *P<0.05 compared to DMSO 
(0.5%) or no treatment. 
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MDCK cells were plated at confluence and treated with GRK inhibitor upon cell 
feeding every 24h. Occludin and ZO-1 localization at the border was reduced on day 3 
following treatment of parental MDCK cells with GRK Inhib 22 (Fig. 3.11 A and B) or 
ABMH (Fig. 3.11 A and C) compared with DMSO control.  Cell packing was attenuated 
by both inhibitors, as demonstrated by a decrease in nuclei number (Fig. 3.11 D) and an 
increase in area within the AJ (Fig. 3.11 E).  Cell viability was not decreased with any of 
the inhibitors (Fig. 3.12). 
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Fig. 3.11: GRK inhibitors decrease TJ border staining and cell number, and 
increase cell size. (A) IF maximum projected images of total occludin and ZO-1 in 
DMSO control, GRK Inhib 22, and ABMH-treated parental MDCK (scale bar: 50 
μm). (B-C) Scoring of occludin and ZO-1 treated with (B) GRK Inhib 22 or (C) 
ABMH. (D) Nuclei counts for DMSO control vs. GRK Inhib 22 and ABMH. (E) 
Quantification of area within the AJ for DMSO control vs. GRK Inhib 22 and ABMH. 
Drug was present from beginning of each run and replenished every 24 hours along 
with fresh media (average of 14 (B-C) or 4 (D-E) images per condition). *P<0.05 
compared to WT Occ or DMSO control. 
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Fig. 3.12: Cell Viability is not decreased by occludin overexpression or tested 
pharmacological agents. Quantification of WST-1 reduction as a measure of 
viability for (A) parental and occludin overexpression cell lines and parental cells 
treated with (B) GRK Inhib 22 and ABMH GRK inhibitors, (C) paroxetine GRK 
inhibitor, or (D) roscovitine cell cycle inhibitor. Data are expressed as Mean ± SD (n = 
8). *P<0.05 compared to WT Occ, 0.5% DMSO, or no treatment. 
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TER was measured in parental cells treated with GRK inhibitors.  Treatment with 
all three GRK inhibitors delayed barrier development in a dose-dependent manner 
yielding lower TER on day 3 (Fig. 3.10 B-D and 3.13 B-E). In contrast to the pan specific 
GRK Inhib 22, inhibitors specific to the GRK 2-3 subfamily (GRK Inhib 63 and 64) did 
not reduce TER (Fig. 3.13 B). Importantly, overexpression of S471D Occ was sufficient 
to attenuate the GRK Inhib 22-mediated TER decrease in MDCK cells while WT Occ 
expression tended to normalize TER but was not statistically significant (Fig. 3.13 F).  
These results strongly implicate GRK isoforms in phosphorylation of occludin S471, and 
that inhibition of GRK isoforms significantly decreases cell packing, TJ assembly, and 
peak TER, which may be attenuated by expression of the S471D Occ phosphomimetic.  
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Fig. 3.13: GRK inhibitors reduce TER in a dose-dependent manner. (A) 
Western blot of all lines showing GRK subfamily 4-6 expression. (B-E) TER 
3 days post confluence of MDCK treated from the beginning of each 
experiment with various GRK inhibitors including (B) GRK Inhibitors 64, 63, 
and 22 (15 μM), (C) GRK Inhibitor 22 (50 μM), (D) ABMH, and (E) 
paroxetine. Data are expressed as mean ± SD (n=4-8), *P<0.05 compared 
to control. (F) Comparison of TER from beginning to end of Day 3 post 
plating, showing ratio of DMSO control to GRK Inhib 22 treatment for each 
cell line. Data are expressed as mean ± SE (n=6-8) and compared using 2-
way ANOVA with Bonferroni post-hoc test. *P<0.05 for parental vs. S471D 
at indicated times. 
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3.5 Discussion 
Despite the importance of barrier formation and dysfunction in a variety of 
diseases, (Morgan et al., 2014; Murakami et al., 2012; Schmitz et al., 1999), the series 
of events leading to barrier maturation remain incompletely characterized.  The present 
study demonstrates the necessity of size reductive proliferation or cell packing, for 
normal barrier maturation and identifies a role for the TJ protein occludin in this process.  
Previous studies have demonstrated that occludin contributes to proliferative control 
and cell cycle progression (Runkle et al., 2011; Wang et al., 2005), is altered in 
epithelial cancers (Gonzalez-Mariscal et al., 2007; Runkle and Mu, 2013), and may act 
as a tumor suppressor (Wang et al., 2005).  Evidence is presented here demonstrating 
that phosphorylation of S471 of occludin regulates entry into size reductive proliferation 
after cell contact.  Expression of an occludin S471 phosphoinhibitory mutant, Occ 
S471A, acts in a dominant manner to attenuate cell packing and subsequent TJ 
maturation, and formation of high resistance barriers. These effects can be 
recapitulated by treating confluent monolayers with a cell cycle inhibitor, demonstrating 
the necessity of cell packing for complete TJ assembly and monolayer maturation.  
Finally, Occ S471 was found to be a substrate for GRK, and three separate GRK 
inhibitors attenuated epithelial cell maturation. The data suggest that GRK 
phosphorylation of Occ S471 signals to allow size reductive proliferation.  The reduced 
cell size then relieves cytoskeletal strain promoting Hippo/MST signaling for YAP 
nuclear exclusion (Aragona et al., 2013) and cellular quiescence with completed TJ 
formation. Inhibition of S471 phosphorylation or preventing cell cycle progression post-
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confluency prevents size reductive proliferation leading to fewer larger cells with 
incomplete TJ formation (Fig. 3.14). 
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Fig. 3.14: Model of occludin S471 contribution to monolayer maturation. (A) 
Increasing confluency leads to contact by E-cadherin extracellular domains of 
adjacent cells (light blue bars). Cell confluency increases and occludin S471 is 
phosphorylated by GRK, allowing size reductive proliferation, decreasing cell area 
and increasing cell number. (B) As cell size decreases, YAP becomes excluded from 
the nucleus and junctional maturation proceeds, yielding a mature monolayer with 
high barrier resistance and proliferative quiescence. (C) Monolayer maturation may 
be perturbed by: (1) Ser to Ala mutation of occludin at S471, (2) cell cycle inhibition 
of newly confluent monolayers, or (3) inhibition of the S471 kinase GRK. (D) In all 
cases, size reductive proliferation is inhibited leaving an immature monolayer with 
complete AJ formation but poor TJ organization and low TER. Cells become 
quiescent despite nuclear localization of YAP and fail to undergo size reductive 
proliferation. 
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TJ barrier regulation by occludin is dependent on phosphosites which are 
particularly abundant in the C-terminal coiled coil (Cummins, 2012).  Occludin 
dephosphorylation is associated with decreased electrical resistance and localization of 
occludin at the membrane, and C-terminal deletion increases solute flux and attenuates 
TJ organization (Andreeva et al., 2001; Balda et al., 1996).  Specific phosphosites 
regulate the occludin-mediated response to various growth factors and cytokines. For 
example, phosphorylation at S490 by PKCβII in response to vascular endothelial growth 
factor treatment increases occludin ubiquitination leading to endocytosis and increased 
permeability (Murakami et al., 2009; Murakami et al., 2012).  S490 phosphorylation also 
facilitates mitotic entry and increases proliferation (Runkle et al., 2011).  
Phosphorylation at S408 mediates interleukin-13-induced barrier loss, and inhibition of 
the S408 kinase, CK2, increases TER through altered inter-molecular complex 
formation within the TJ (Raleigh et al., 2011).  Specific occludin phosphosites also 
regulate occludin’s interaction with other TJ proteins, suggesting additional points of 
regulation (Dorfel et al., 2013; Elias et al., 2009; Suzuki et al., 2009).  These studies 
support a role for specific occludin phosphosites in barrier regulation and suggest that 
novel sites may have important regulatory roles. 
Overexpression of non-phosphorylatable S471A Occ disrupted cell packing and 
maturation of TJs but not AJs.  AJs are formed prior to TJs following cell-cell contact, 
and while TJ and cytoskeletal organization were decreased in a dominant fashion in 
S471A Occ lines, AJ assembly was unaffected, revealing that AJ formation does not 
require cell packing as TJ formation does. Further, GRK inhibition did not alter AJ 
formation.  Additionally, S471A Occ monolayers were composed of fewer cells with 
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increased area suggesting premature proliferative cessation. The Hippo/MST signaling 
pathway is an important determinant of cell and organ size, and nuclear exclusion of the 
co-activator, YAP, accompanies proliferative quiescence.  While YAP is just one of 
several nuclear Hippo/MST proteins, proliferative cessation in S471A Occ cell lines 
despite continued nuclear YAP localization indicates a dominant effect of the mutant, 
leading to premature arrest of packing prior to completion of the Hippo/MST signaling 
pathway.  
S471A Occ expression reduced TER despite similar TJ protein expression and 
Ca2+, K+, and Cl- ion permeability in all lines (Fig. 3.8 D-F), suggesting non-specific flux 
from gaps in the TJ rather than altered expression of claudins, or claudin pore formation 
to induce changes in permeability of a specific ion.   Importantly, packing deficiencies 
evident in S471A Occ lines including mislocalized TJ proteins and reduced TER were 
recapitulated by pharmacological inhibition of packing alone, indicating that packing is 
necessary for establishing anatomically and functionally normal barriers. It is noteworthy 
that many TJ proteins appear at the cell border upon contact and before packing but 
that a continuous apical TJ is not completed until after size reductive proliferation and 
quiescence. How these downstream events are regulated remains an area for future 
investigation. 
Structural analysis of occludin and ZO-1 binding suggests that occludin S471 is 
located within the acidic head of the coiled-coil that specifically binds the GuK domain of 
ZO-1 (Tash et al., 2012), raising the possibility that occludin S471 phosphorylation could 
affect the conformation of ZO-1 and thus epithelial maturation. The ZO family acts to 
organize cell junctions and links the junction to the actin cytoskeleton (Gonzalez-
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Mariscal et al., 2000). Changes in localization of all the TJ proteins analyzed in the 
S471A Occ mutants as well as altered actin organization, particularly at the cortical ring, 
are consistent with an alteration in proper ZO-1 function at the cell membrane. Occludin 
expression is not necessary for TJ formation in the intestinal epithelia of mice or in 
MDCK cells (Schulzke et al., 2005; Yu et al., 2005), suggesting that the regulatory effect 
of occludin may eventually be compensated for in its absence.  However, the effect of 
the S471A mutation was not transient, indicating that the presence of non-
phosphorylatable S471 occludin inhibits packing and TJ formation in a dominant 
manner and revealing this site as a regulator of size reductive proliferation and epithelial 
maturation.   
GRKs can phosphorylate S471 Occ, and inhibition of GRKs recapitulates results 
obtained with S471 Occ lines and cell cycle inhibition.  GRKs contribute to signal 
transduction desensitization by phosphorylating G-protein coupled receptors and 
preventing coupling with cytoplasmic G-proteins.  The sequence surrounding Occ S471 
was tested in multiple kinase prediction software programs, and 41 kinases were 
selected for screening.  GRK family members were able to phosphorylate the Occ 
S471-containing peptide consistent with recent studies demonstrating that non G-
protein coupled receptor proteins including cytoskeletal (Chakraborty et al., 2014), 
nuclear (Martini et al., 2008), and membrane proteins (Dinudom et al., 2004), as well as 
transcription factors (Patial et al., 2010), can be GRK substrates.  Seven GRK isoforms 
have been identified and are divided into three subfamilies based on sequence 
homology: isoforms 1 and 7 are tissue specific to the eye while 2 and 3 are ubiquitously 
expressed, as are isoforms 5 and 6 while isoform 4 has limited expression (Gurevich et 
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al., 2012).  Importantly, three structurally distinct GRK inhibitors were able to 
recapitulate deficiencies in packing and TJ protein localization evident in S471A Occ 
lines in a dose dependent manner.  In contrast to the pan-specific GRK Inhib 22, two 
inhibitors with greater specificity to the 2-3 subfamily did not decrease TER.  This result 
along with a lack of GRK 1 and 7 expression in kidney and confirmed expression of the 
GRK 4-6 subfamily in MDCK cells by Western blot suggests that at least one member of 
the GRK 4-6 subfamily is an S471 kinase in MDCK cells.  Silencing of GRK5 increases 
cell area, decreases tumor size (Chakraborty et al., 2014), and attenuates proliferation 
in various cancer lines (Kaur et al., 2013; Kim et al., 2012), demonstrating a regulatory 
role for the 4-6 subfamily in cell size and proliferation.  While off target effects of GRK 
inhibitors used in the current experiment likely exist, the ability of three structurally 
distinct inhibitors to induce the same effect preventing epithelial maturation strongly 
suggests GRK as the target.  Critically, the GRK inhibitor-mediated TER decrease 
observed in parental MDCK was significantly attenuated in the phosphomimetic S471D 
Occ overexpressing cells, implicating Occ S471 as a critical GRK target in epithelial 
maturation. 
Taken together, these observations support a model in which Occ S471 
phosphorylation contributes to the regulation of entry into size reductive proliferation 
after contact, followed by epithelial quiescence and assembly of TJs at the cell border 
leading to a high resistance barrier and a mature monolayer.  These findings extend the 
current understanding of the role of occludin, and establish the importance of cell 
packing in barrier formation. 
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CHAPTER IV 
 
Negative Charge at Occludin S471 is Not Necessary in vitro For Proper 
Localization and Organization of Tight Junction Proteins at the Border2 
 
4.1 Abstract 
 Serine phosphorylation is a ubiquitous post-translational modification that acts as 
a molecular switch by which cells can turn various signaling pathways off and on to 
respond to internal or external conditions.  Signaling can result from changes in protein-
protein interactions mediated by phosphorylation status, as the addition or subtraction of 
a phosphorylation group can alter interactions within or between proteins.  Previous 
experiments indicate that expression of a mutation at the S471 residue perturbs 
epithelial maturation and TJ formation.  The current study examines the structural 
consequence of these mutations, and investigates the role of the negative charge 
carried by phosphorylation groups on the coiled-coil structure.  WT Occ, S471A, and 
S471N occludin are transiently expressed in MDCK cells and compared with previous 
findings in WT Occ, S471A, and S471D lines.  TJ proteins are well organized at the 
border in WT Occ but not in S471A lines, consistent with previous findings.  S471N cells 
phenocopy WT Occ and previous S471D organization, despite asparagine (N) lacking a 
negative charge on its side chain.  These results indicate that the negative charge is not 
necessary for TJ organization, and suggest that other molecular interactions provided 
by the phosphorylated serine are responsible. Modeling of S471 in phosphorylated and 
                                                          
2
 Portions of this chapter are included in a manuscript in preparation for a yet to be determined journal 
88 
 
non-phosphorylated forms suggest hydrogen bonding to Arg468 may stabilize the 
coiled-coil domain of occludin. 
 
 4.2 Introduction 
Protein-protein interactions are important determinants of cell function and 
behavior, and contribute to cell-cell signaling, signaling cascades, and transcriptional 
control.  Interactions between associated proteins occur at the molecular level and are 
influenced by factors such as polarity, charge, 3 dimensional structure (sterics), and 
proximity between specific protein residues.  This is exemplified by the TJ protein, 
occludin, which binds to the scaffolding protein ZO-1.  ZO-1 is a member of the MAGUK 
protein family, which is characterized by a catalytically inactive GuK domain that acts as 
a p-Ser/p-Thr binding domain (Lye et al., 2010; Zhu et al., 2011, See chapter 2).  
Characterization of other MAGUK and phosphorylated target binding interactions 
indicate important and separable binding domains for the interaction of both the p-Ser 
site, regulating the binding interaction and the nearby residues, yielding target specificity 
(Zhu et al., 2011). In these interactions, the MAGUK binding was dependent on 
phosphorylation while occludin and ZO-1 interaction do not require S471 
phosphorylation; however, peptide binding studies reveal higher peptide binding with 
phosphorylation of S471 in an occludin peptide to the ZO-1 MAGUK (Tash et al., 2012). 
MAGUK contact sites include specificity binding region and phosphosite binding region. 
The specificity binding region restricts binding to specific substrate proteins while 
phosphosite binding region interacts with p-Ser/p-Thr (Zhu et al., 2011). In the case of 
the occludin-ZO-1 interaction, there is an electrostatic attraction between the relevant 
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protein domains conferring specificity.  Specifically, the glutamic acid-rich and thus 
negatively charged C-terminal coiled coil head region of occludin interacts with ZO-1 at 
the face of its lysine rich, positively charged guanylate kinase (GuK) domain (Li et al., 
2005; Tash et al., 2012), see chapter 3 for discussion).  Previous studies suggest that 
glutamic acid residues flanking S471 on the coiled-coil interact with ZO-1 specificity 
sites, as negative to positive charge-reversal mutations at these residues decrease ZO-
1 binding (Tash et al., 2012).  In contrast, though S471 is a phosphorylatable residue, a 
charge-reversing S to K mutation at S471 at the center of the coiled-coil and interaction 
site minimally affects ZO-1 binding, indicating that S471 negative charge does not 
improve binding.  Taken together, these findings suggest that occludin acts as a ZO-1 
binding substrate, that residues E469-470 and E472-473 of occludin interact with ZO-1 
GuK specificity sites, and that S471 interacts with an as yet unidentified phosphosite 
binding domain of the ZO-1 MAGUK and may be an important residue for mediating the 
effects of the occludin-ZO-1 interaction. 
Occludin S471 is important for overall protein and TJ function, and 
overexpression of a phosphoinhibitory S471A form disrupts TJ assembly and function 
(see chapter 3 results and discussion).  S471A expression does not, however, decrease 
the occludin-ZO-1 interaction as observed by Co-IP experiments, consistent with S471 
interacting with a phosphosite binding domain that is not required for protein-protein 
interaction (Tash et al., 2012, Fig. 3.3).  However, abolition of the occludin-ZO-1 
interaction is not the only alteration that could alter function of either protein.  The 
possibility remains that S471A could perturb the conformation/stability of the occludin 
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coiled-coil, leading to other, currently uncharacterized changes in ZO-1 interaction and 
function or interactions with other proteins. 
The current study was part of a larger effort to investigate the effects of occludin 
S471 phosphorylation at the molecular level.  Our collaborators John Flanagan and 
Maria Bewley at Pennsylvania State University found that expression of either S471A or 
S471D results in structural changes throughout the occludin coiled coil compared to 
non-phosphorylated WT.  The changes observed upon S471D expression were 
surprising and in contrast to the hypothesized stabilizing effect of S471 phosphorylation.  
Serine phosphorylation changes the charge of the residue from polar uncharged to 
negative, but also changes the 3 dimensional structure by adding a phosphate group 
that is sterically larger and bulkier than unphosphorylated serine.  Crystal structure and 
modeling data suggest that non-phosphorylated S471 interacts via hydrogen bond with 
Y474, and that phosphorylation enables hydrogen bonding with nitrogen both at the 
carboxyl backbone and near the side chain distal imine of R468.  It remains unclear 
whether the contribution of S471 phosphorylation is due to the permanent negative 
charge carried by the phospho group or to other factors such as hydrogen bonding with 
nearby residues.  The objective of the current study was to re-evaluate the in vitro 
effects of S471 phosphoinhibitory and phosphomimetic mutant occludin in TJ border 
localization, and to determine if the effects of S471 phosphorylation were due to charge 
or some other factor.  Evidence is presented indicating that negative charge at S471 is 
not necessary for bTJ localization, implicating other, charge-independent factors.   
 
4.3 Methods 
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TROSY NMR and molecular modeling 
WT, S471A, and S471D mutant occludin coiled-coil domain was raised in E. coli 
vector and analyzed for structural differences using transverse relaxation-optimized 
spectroscopy nuclear magnetic resonance (TROSY NMR).  Coiled-coil confirmation and 
hydrogen bonding was then modelled for WT, p-WT, S471D, and S471N coiled-coil 
using Chimera software (Biocomputing, Visualization, and Informatics, University of 
California San Francisco). 
Cell culture 
All reagents were purchased from Sigma Chemical (St. Louis, MO) unless 
otherwise noted.  Madin Darby canine kidney (MDCK) cells were obtained from 
American Type Culture Collection (Manassas, VA) and cultured in minimum essential 
media as previously reported (Runkle et al., 2011).  All cells were kept at 37°C with 5% 
CO2. 
Fusion protein constructs 
Fusion protein constructs were generated by inserting cDNAs encoding WT 
human occludin or S471A mutant occludin into a pmaxFP expression vector (Amaxa, 
Cologne, Germany) following manufacturer instructions.  An S471N construct was then 
generated using the WT Occ protein construct and Quik Change Site-Directed 
Mutagenesis Kit, following manufacturer instructions (Agilent Technologies, Santa 
Clara, CA).  Mutagenesis primers were 
GGATGACTATAGAGAAGAAAATGAAGAGTACATGGCTGC (forward) and 
GCAGCCATGTACTCTTCATTTTCTTCTCTATAGTCATCC (reverse).  Resulting 
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plasmids were sequenced to confirm serine to asparagine mutation.  Images of amino 
acid structures were created in ChemDraw (PerkinElmer, Waltham, MA). 
   Transient transfections 
WT Occ, S471A, and S471N were transiently transfected in to MDCK cells using 
lipofectamine 3000 and following manufacturer instructions.  Cells were approximately 
90% confluent at transfection.  
Immunofluorescence 
Cells were plated on chambered glass slides and fixed on the fourth day post 
transfection (three days post-confluent), with 3.5% paraformaldehyde (PFA) for 10 
minutes (Thermo Scientific, Waltham, MA).  Fixation was followed by 15 minutes 
permeabilization in TBS plus 0.25% triton-x 100.  Cells were blocked in 10% goat serum 
(Life Technologies, Carlsbad, CA) with 0.25% triton-x 100 for 1 hour, then stained with 
GFP-occludin (Evrogen, Moscow, Russia), total occludin (Invitrogen, Carlsbad, CA), or 
ZO-1 (Millipore, Billerica, MA) primary antibodies overnight at 4°C and 1:200 (total 
occludin and ZO-1) or 1:400 (GFP) dilution in blocking solution.  Secondary antibody 
(Alexa Fluor 488, 555, and 647, Life Technologies, Carlsbad, CA) exposure was 1 hour 
at room temperature in blocking buffer at a 1:1,000 dilution.  Fluorescence was 
determined from Z-stacks of 0.5 µm slices taken on a Leica TCS SP5 confocal 
microscope (63x, 1.4 N.A oil objective, Wetzlar, Germany) with photomultiplier tube 
detectors, and using Leica Advanced Fluorescence software.   
Tight junction width quantification and 3 dimensional projections 
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TJ width was quantified from confocal IF images using Metamorph software 
(Molecular Devices, Sunnyvale, CA).  Border width was quantified by measuring GFP 
intensity along the border of adjacent cells both expressing GFP-occludin compared to 
borders of GFP-occludin expressing cells adjacent to non-GFP occludin expressing 
cells.  IF staining was modeled by converted confocal IF files to 3 dimensional 
projections using the Imaris Software surface function (Bitplane, Belfast, UK). 
Statistical analysis 
Border width was normalized to WT Occ lines and compared in GFP-occludin-
GFP-occludin borders as well as GFP-occludin non-GFP expressing borders via 
ANOVA followed by Bonferroni Post-hoc test (Prism 5.0 GraphPad Software, La Jolla, 
CA).  Data are expressed as mean ± SD, and P<0.05 was considered statistically 
significant. 
 
4.4 Results 
S471 mutant occludin perturbs the occludin coiled-coil. To evaluate the effect of 
S471 phosphorylation status on the structure of the occludin coiled-coil, our 
collaborators performed transverse relaxation-optimized spectroscopy (TROSY) NMR 
experiments on WT, S471A, or S471D occludin coiled-coil.  Both S471 mutations 
induced allosteric conformation changes within the coiled-coil (Fig. 4.1). 
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Phosphorylated S471 hydrogen bonds with neighboring residues. 
This surprising result led us to investigate the effects of specific molecular 
interactions such as electrostatic attraction and hydrogen bonding in phosphorylated 
and non-phosphorylated S471.  Our collaborators relied on known crystal structures and 
modeling to identify molecular interactions with nearby residues within the coiled-coil.  
Fig. 4.1: S471 mutant occludin perturbs the occludin coiled-coil.  Individual 
residues were resolved in WT (blue), S471A (red), and S471D (green) mutant occludin 
coiled-coil by TROSY NMR.  Non-overlap of colors indicates a structural perturbation 
(Courtesy of Flanagan/Bewley Laboratory, Pennsylvania State University). 
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Phosphorylated and non-phosphorylated WT Occ as well as S471D and S471N mutant 
occludin are predicted to hydrogen bond from a side chain oxygen to a nitrogen on 
Y474 (Fig. 4.2), while S471A occludin is not (data not shown).  Additionally, 
phosphorylated WT Occ, S471D, and S471N occludin are predicted to make two (p-WT 
Occ) or one (S471D and S471N) hydrogen bonds to R468 (Fig. 4.2). Thus, the 
phosphorylated S471 is predicted to form the most stabilized interaction with additional 
residues of the coiled-coil. The stabilized hydrogen bonding of S471N equivalent to 
S471D but without the negative charge addition allowed a direct assessment of the 
contribution of charge at Ser471 on organization of occludin into tight junctions. 
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S471 side chain negative charge is not necessary for in vitro TJ organization. 
To evaluate the role of phosphorylation related negative charge on the occludin 
S471 sidechain in cells, MDCK cells were transiently transfected to overexpress GFP-
tagged WT, S471A, or S471N mutant occludin.  The alanine sidechain is uncharged 
Fig. 4.2: Phosphorylated serine and phosphomimetic mutants hydrogen bond 
to R468.  Crystal structure of WT Occ coiled-coil and models of p-S471, S471D, and 
S471N showing carbon (gray), oxygen (red), nitrogen (blue), and phosphorus 
(yellow).  Confirmed and predicted hydrogen bonds are indicated by dotted lines with 
proximity given in angstroms (Courtesy of Flanagan/Bewley Laboratory, 
Pennsylvania State University). 
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and lacks the necessary groups to hydrogen bond while asparagine is also uncharged, 
but is able to hydrogen bond and is structurally very similar to the phosphomimetic, 
aspartic acid (Fig. 4.3).  WT Occ lines carry the native serine, which is presumably 
phosphorylated during monolayer maturation. 
 
 
 
 
Analysis of borders between adjacent cells expressing WT exogenous GFP-
occludin revealed crisp, well organized occludin and ZO-1 staining at the border, 
consistent with previous stable cell line experiments (Fig. 4.4 A-B, and see Fig. 3.2).  In 
contrast, S471A staining for GFP and total occludin between two GFP-occludin 
expressing cells was broad and poorly organized at the border, again consistent with 
previous results (Fig 4.4 A-B, and see Fig. 3.2), while ZO-1 staining was conspicuously 
absent.  S471N cell borders were well organized and very similar to WT in appearance 
for both occludin and ZO-1 (Fig. 4.4 A-B).  Quantification of GFP-occludin border 
staining width for each occludin mutant confirmed disrupted protein localization in 
Fig. 4.3: Amino Acid Structures.  Schematic of relevant amino acids.  P-serine and 
aspartic acid carry negative charges on their side chains, while serine, alanine, and 
asparagine do not. 
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S471A expressing cells as evidenced by broader GFP-occludin staining compared to 
WT Occ and S471N (Fig. 4.4 C).  This effect was evident only in borders between two 
cells expressing the mutation, and no difference was observed between the various 
mutations in borders between a cell expressing exogenous occludin and one that did 
not (Fig. 4.4 D).   
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Fig. 4.4: WT Occ and S471N cell have well organized bicellular borders while 
S471A cells do not.  MDCK cells transiently expressing exogenous GFP human 
occludin with no mutation (WT), S to A, or S to N point mutation at S471.  (A) 
Immunofluorescence and (B) 3-dimensional modelling of indicated protein with white 
stars indicating cells expressing GFP-occludin and white arrows indicating poorly 
organized bicellular borders.  Quantification of distance across the border of (C) two 
cells expressing GFP-Occludin as a measure of border organization, or (D) a control 
border between a GFP-Occludin expressing cell and a non-expressing cell.  Data are 
expressed as mean ± SD (n = 7-14).  *P<0.05 compared to WT Occ. 
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4.5 Discussion 
Amino acid phosphorylation is a post-translation modification that is crucial for 
signal transduction (Burnett and Kennedy, 1954; Thorner et al., 2014), and changes the 
amino acid side chain in at least two fundamental ways: it adds a negative charge, and 
a phosphate group that is sterically large.  The phosphomimetic serine to aspartic acid 
point mutation effectively mimics phosphorylation electrically, but not sterically as the 
carboxylic acid side chain of aspartic acid carries a negative charge, but is not as bulky 
as a phosphate group.  Phosphorylated serine hydrogen bonds with R468, and 
modelling of S471D indicates that a bond is still made with R468 despite the lack of 
bulk. 
Previous studies with MDCK cells show that (presumably phosphorylated) WT 
Occ and S471D lines have well organized TJs at the borders, and transiently 
transfected WT Occ recapitulated this finding.  TJ borders were also well organized in 
transiently transfected S471N cells.  Since the asparagine side chain is uncharged, this 
result indicates that the negative charge found on aspartic acid or phosphorylated 
serine is not necessary for TJ organization, and the effect of phosphorylation is 
mediated by some other type of interaction.  The identity of this factor remains elusive, 
but one possibility is hydrogen bonding.  Importantly, non-phosphorylated WT Occ is not 
equivalent to S471A due to the lack of S471-Y474 hydrogen bonding in the later.  This 
interaction is present in both phosphorylated and non-phosphorylated WT Occ however, 
as well as in S471D and S471N.  Therefore, loss of Y474 hydrogen bonding would not 
account for the observed coiled-coil perturbation between non-phosphorylated WT Occ 
and S471D.   A model is proposed in which occludin is phosphorylated at S471 at high 
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confluency, allowing for hydrogen bonding between S471 and R468 and stabilizing the 
coiled-coil in a confirmation favorable for initiation of TJ assembly.  Given the 
dependence of TJ organization on packing through size reductive proliferation (chapter 
3), this stabilized confirmation would presumably contribute to size reductive, confluent 
proliferation in some way, allowing for packing and TJ formation.  S471 could then be 
dephosphorylated once a critical cell area (the transition point, see chapter 3) was 
reached, leading to loss of R468 hydrogen bonding, perturbation of the coiled-coil, and 
proliferative quiescence, or quiescence may be achieved through alternative signaling 
and S471 phosphorylation may be maintained.  Additional studies will be necessary to 
evaluate the validity of this and alternative models. 
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CHAPTER V 
Conclusions, Limitations, and Future Directions 
5.1 Overall summary and conclusions 
Recent findings concerning the participation of AJC proteins in non-canonical 
roles have changed the view of these junctions from static structures mediating only 
permeability/adhesion, to dynamic protein reservoirs that can participate through cell 
signaling in response to extracellular stimuli.  The characterization of the novel occludin 
S471 site presented in this dissertation is consistent with this expanding role of AJC 
proteins, and with the already complex role of occludin.  Previous publications in 
prestigious journals have already described in part the dynamics of epithelial cells at low 
and high confluency, the existence and size reductive nature of confluent proliferation, 
and the role of biophysical forces in this process (Aragona et al., 2013; Dupont et al., 
2011; Puliafito et al., 2012).  However, what was not appreciated, and is presented in 
the current dissertation, is the necessity of this monolayer maturation for barrier 
formation and the contribution of the occludin S471 site in this process.  This 
dissertation links S471 phosphorylation to confluent proliferation, possibly as a 
checkpoint for its induction, as phosphoinhibitory (S471A) lines proliferate normally 
when subconfluent, but fail to initiate confluent proliferation.  In this way, occludin 
influences the morphological characteristics of the monolayer and its constituent cells, 
but also affects TJ protein localization and the ultimate resistance of the barrier.  The 
failure of S471A lines to undergo confluent proliferation and cell packing leaves 
monolayers with larger and less numerous cells at confluence, and as a result, poorly 
organized TJs and low resistance barriers.  S471 phosphorylation may act as a 
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molecular switch that when phosphorylated, allows induction of confluent proliferation 
while preventing it when phosphorylation is prevented.  Studies investigating the 
molecular consequences of phosphorylation within the occludin coiled-coil are 
presented and indicate that negative charge at S471 is unnecessary for TJ organization 
in cells.  This suggests that some other consequence of S471 phosphorylation within 
the coiled-coil is responsible, potentially specific hydrogen bonding with R468, which is 
predicted to be present only when S471 is phosphorylated.  S471 may also interact with 
the nearby occludin Tyr474 phosphosite, which has been identified as required for 
localization at the leading age of migrating MDCK cells, and binds to PI3-kinase 
regulating cytoskeletal rearrangement (Du et al., 2010).  In summary, the studies 
presented in this dissertation demonstrate roles for occludin S471 in proliferation, TJ 
organization, barrier resistance, and monolayer maturation.  Additionally, an 
S471kinase is identified (GRK) and preliminary results of intra coiled-coil molecular 
interactions are reported.  S471 is added to the list of confirmed, characterized occludin 
phosphosites including S408, S490, Y474 and S508, that mediate responses to specific 
stimuli, and facilitate the versatile and complex functions of the TJ protein, occludin. 
 
5.2 Limitations 
The approaches in this dissertation were sufficient to elucidate the importance of 
cell packing for monolayer maturation, the role of occludin in this process, and some of 
the atomic interactions within the occludin coiled-coil that may contribute to these 
effects.  The studies were not, however, without limitations.  The first is that the work 
was done in vitro and in cell lines.  The nature of the questions under investigation 
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dictated that a simple model be used that would not have the complexity of animals or 
the time required for breeding.  As with any in vitro study however, there may be 
limitations as to the external validity of our findings to other types of cells and to 
organisms.  Additionally, the difficulty of transfecting or transducing MDCK cells led to 
the use of selected clonal cell lines.  This carries with it the risk that a phenotype may 
be due to some unrelated mutation in a specific line rather than the mutation of interest, 
although multiple lines were used to mitigate this risk.  Additionally, a key early finding 
was that S471A did not decrease the occludin-ZO-1 interaction.  This conclusion was 
made based on Co-IP experimental results, but ZO-1 has contacts with many other TJ 
proteins, and is likely part of a large protein complex. Limitations of the Co-IP technique 
leave the possibility that S471A does decrease the occludin-ZO-1 interaction, but that 
they are both pulled down anyway due to a mutual binding partner or additional contact 
sites on the two proteins. 
Finally, phosphoinhibitory and phosphomimetic mutations are mimics of 
phosphorylated or non-phosphorylated serine.  Alanine and aspartic acid are good 
approximations of non-phosphorylated and phosphorylated serine, respectively on the 
basis of side chain charge, but both have key deviations in terms of 3D structure.  Non-
phosphorylated serine hydrogen bonds to the nearby Y474 backbone with its side chain 
hydroxyl group, a bond that cannot be made by the methyl side chain of alanine.  How 
loss of this specific bond might affect coiled-coil stability is unknown.  Aspartic acid 
differs from phosphorylated serine in that its side chain is a simple carboxylic acid, and 
therefore far less bulky than a phosphorylated serine.  This difference has the potential 
to disrupt interactions that would be present with a phosphate group, particularly 
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hydrogen bonds, due to lack of proximity.  In this case, our data suggests the S471D 
only makes one hydrogen bond with the nearby R468 rather than two like 
phosphorylated serine.  No results were obtained at any point in these studies 
suggesting that S471D is anything less than a capable mimic of phosphorylated serine, 
but the effects of this reduction in bond number are unknown.   
 
5.3 Future Directions 
This dissertation describes many of the upstream events associated with S471 
phosphorylation and its effects on monolayer maturation.  These results provide some 
answers, but also raise many questions, and provide opportunities for further 
investigation.  These include further studies of occludin S471 and broader questions of 
epithelial cell biology. 
A logical addition to the findings in this dissertation would be the extension of 
applicability by testing GRK inhibitors or expressing S471A in other cell lines.  This 
could include epithelial cells (Caco-2, HeLa), endothelial cells (BREC, HUVEC), or 
transgenic animals.  Animal studies could include WT or mutant occludin knockin mice 
generated using emerging Crispr/cas9 technology.  This dissertation also includes initial 
results from additional in vitro studies, which should be completed.  Preliminary data 
indicates that the area of S471D cells is decreased compared to controls, even when 
subconfluent.  This is a provocative result, and suggests that S471 phosphorylation is 
sufficient for size reductive proliferation.  Additional experiments of cell area and 
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proliferative rates in subconfluent cells should be conducted to evaluate these initial 
findings. 
A significant hurdle in explaining the downstream effects of S471A expression is 
the finding that S471A lines become proliferatively quiescent despite largely nuclear 
YAP (chapter 3).   This is contrary to the prevailing view that YAP is nuclear only during 
proliferation, and indicates that this proliferative arrest is YAP independent.  
Furthermore, the normal subconfluent proliferation evident in these cells suggests that 
subconfluent and confluent (size-reductive) proliferation are separable processes, with 
subconfluent proliferation mediated by Hippo/MST, Wnt, biophysical forces, etc., and 
confluent proliferation mediated by an undescribed mechanism.  If true, this dissertation 
describes a disruption in a pathway that is not yet known to exist.  This adds significant 
complexity to understanding the S471 downstream mechanism, and dictates that further 
insights into the process of confluent proliferation may be necessary before the S471 
mechanism can be fully appreciated.  Conclusions can be made on the basis of this 
work that inhibition of S471 phosphorylation does not abolish the occludin ZO-1 
interaction, does not result in endocytosis of occludin, and does not release any factor 
which disorganizes WT cell TJs (Fig. 3.3).  Initial efforts at elucidating the true 
mechanism should focus on narrowing down potential areas of long term inquiry. 
A good starting point would be to characterize subconfluent and confluent 
proliferation and cell area in occludin KD, or occludin/tricellulin/marvelD3 (TAMP) KD 
cells.  Occludin KD cells have been generated with no reports of proliferative or packing 
abnormalities, but cell packing has not been specifically studied in these cells, and 
these experiments would answer questions about the necessity of occludin in confluent 
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proliferation.  The documented compensation for occludin by TAMP family members 
may require that tricellulin and marvelD3 be silenced as well.  Another worthwhile study 
would be to look for changes in overall or fractionated (nuclear, cytosolic, etc.) protein 
pools by Co-IP and mass spectroscopy, or of transcription-related changes by 
chromatin immunoprecipitation or electrophoretic mobility shift assays in control vs. 
S471A lines for both subconfluent and confluent conditions.  A number of commercially 
available protein microarrays could also be used to probe for differences in protein 
expression or phosphorylation status.  The goal of any of these experiments would be to 
identify proteins, phosphorylation events, or transcription factors/co-activators that differ 
between S471A and controls, and could help identify possible mechanisms. 
Finally, the effects of S471A on proliferation suggest the involvement of a 
proliferative signaling pathway, and the contribution of marvelD3 to JNK signaling 
provides precedence for such an association in the TAMP family (Steed et al., 2014).  
The occludin Y474 site is a candidate for this type of association, as it is known to 
interact with and activate the p85 subunit of PI3K, allowing for organization of polarity 
proteins and the actin cytoskeleton (Du et al., 2010).  Combined with known hydrogen 
bonding between Y474 and S471 (see chapter 4), this raises the tantalizing possibility 
that some connection such as facilitated phosphorylation may exist between Y474 and 
S471 in regulating PI3K, which could explain in part the effects of S471A mutants on 
proliferation.  Preliminary studies examining tyrosine phosphorylation following GFP-
occludin IP of WT or S471A Occ lines failed to demonstrate any differences in 
phosphorylation, but a general PY20 antibody was used (Fig. 3.5).  Simple blots for 
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PI3K/Akt signaling could be performed followed by further trials with a PY474 specific 
antibody, which would better evaluate this possibility. 
In terms of broader research directions, a conceptually simple yet promising 
research direction would be to determine the true role of TAMP family transmembrane 
proteins through multiple KD/KOs.  Perhaps the largest confounder in the study of 
occludin over the last 15 years has been skepticism over its importance due to the 
perceived lack of phenotype of the occludin KO mouse (see chapter 3, (Saitou et al., 
2000; Schulzke et al., 2005).  Evidence has now emerged however showing that the 
TAMP family member, tricellulin, compensates at least in part for occludin (Ikenouchi et 
al., 2008; Krug et al., 2009), and it seems likely based on homology that the recently 
discovered family member, MARVELD3, may compensate as well.  Knocking out all 
three proteins would prevent this compensation, and could show the true role of 
TAMPs. 
Studies presented in this dissertation demonstrate the impact of monolayer 
maturation upon barrier functionality, providing justification for further investigation of 
maturation-associated mechanisms such as confluent proliferation.  If an 
uncharacterized pathway for confluent proliferation exists, other components besides 
occludin are certainly involved.  An approach for beginning to identify these components 
while further characterizing proliferation and monolayer maturation would be to employ 
a forward genetic screen in a model organism like Drosophila melanogaster or Danio 
rerio (zebrafish).  A population could be screened following exposure to a mutagen, and 
individuals expressing proliferative or morphological abnormalities in cell monolayers 
could be further studied with the objective of identifying additional components of the 
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pathway.  Any individual expressing monolayers that phenotypically resemble S471A 
cells would provide solid footing on which to start further investigations. 
  Finally, the ultimate goal of all biomedical research is to produce knowledge or 
treatments to improve human health, and questions of TJ and barrier biology are very 
relevant to the study of cancer.  As previously described (chapter 2), AJC proteins play 
a significant role in proliferation and cancer development, especially in the context of 
cellular phenotypic transitions.  Within this area, extensive study has been dedicated to 
the role of EMT in cancer including the loss of AJC proteins, the acquisition of a 
mesenchymal phenotype, and the resulting increase in metastatic potential.  Very 
recently though, MET has been implicated in the development of secondary tumors 
following the arrival of metastasizing cells at their destination.  Comparatively little study 
has been dedicated to MET, and opportunities exist in characterizing the phenotypic 
plasticity, AJC protein expression, and CIP/CIL expression of post-MET cells.  This 
exciting area could apply knowledge of barrier biology and monolayer maturation to a 
significant and common pathology, and lead to future therapies to reduce or prevent 
metastasis. 
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